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ABSTRACT
Type 2 diabetes mellitus (T2DM) is a chronic disease characterized by increased amounts of glucose in
the blood, and is the seventh leading cause of death in the United States (United Health Foundation
[UHF]), 2021). T2DM can be effectively treated with medication and behavioral lifestyle modifications.
Even small improvements in glycemic control can reduce the risk for debilitating complications such as
heart disease, stroke, kidney disease, sepsis, and retinopathy (Wang et al., 2021, Haider et al., 2019).
The purpose of this evidence-based practice (EBP) project was to identify the most effective intervention
for improving medication adherence, lifestyle changes, and hemoglobin A1C (HbA1c). Participants were
recruited from a primary care practice in Northwest Indiana. Eligible participants included adults aged 18
to 65 years old, with a diagnosis of T2DM, HbA1c greater than 7%, and prescribed one or more OAD
medications. Participants completed a questionnaire containing the eight-item Morisky Medication
Adherence Scale (MMAS-8) to assess medication nonadherence, and two Likert scale questions on diet
and exercise to assess lifestyle changes before and after the 12-week practice change. HbA1c was
collected prior to and after the practice change of receiving one daily one-way text message reminder to
take their OAD medications, brief diabetic education, and/or motivational text messages focused on
healthy eating habits and exercise. Data was analyzed using a Wilcoxon Signed Ranks matched pairs ttest to compare the pre-and post-intervention MMAS-8 scores and HbA1c data. Statistically significant
differences were noted between the pre and post HbA1c levels (p-value = .002) and the pre and post
MMAS-8 scores (p-value = .004). The Spearman correlation test was performed to show correlations
between the pre-and post-MMAS-8 scores and HbA1c, and lastly a Kruskal-Wallis test was used to show
if diet and exercise played a role in improving HbA1c. Findings from this project support the use of this
simple and cost-effective mobile intervention in the management of diabetic patients in a primary care
setting.
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CHAPTER 1
INTRODUCTION
Background
Type 2 diabetes mellitus (T2DM), formerly known as “adult-onset” or “non-insulin
diabetes mellitus” accounts for 90-95% of those with DM (Centers for Disease Control and
Prevention [CDC], 2021). T2DM is a chronic disease characterized by increased amounts of
glucose in the blood also known as hyperglycemia. Naturally, when the blood glucose rises in the
body, it signals the pancreas to release insulin, and then the insulin carries the blood glucose
into the body’s cells for use as energy (CDC, 2021). In T2DM, the pancreatic beta cells fail to
secrete insulin to lower glucose in the blood and the body’s tissues do not respond appropriately
to insulin, resulting in a worsening metabolic state that can cause serious health problems such
as heart disease, vision loss, and kidney disease (Galicia-Garcia et al., 2020, CDC, 2021).
According to the American Diabetes Association (ADA), the criteria for the diagnosis of
T2DM consists of either hemoglobin (HbA1c) ≥ 6.5%, or fasting plasma glucose (FPG) ≥ 126
mg/dL (7mmol/L), or 2-hour plasma glucose ≥ 200 mg/dL (11.1 mmol/L) during an oral glucose
tolerance test (OGTT), or in a patient with classic symptoms of hyperglycemia (polyuria,
polydipsia, and nocturia), or a random plasma glucose (RPG) ≥ 200 mg/dL (11.1 mmol/L) (ADA,
2021).
In addition to genetics and aging playing a role in the development of T2DM,
environmental factors such as overeating and sedentary lifestyle play even a larger role. Being
overweight or obese, which is defined as a body mass index (BMI) of 30 or higher, is a major risk
factor for T2DM (CDC, 2021). Other risk factors for developing T2DM are prediabetes, 45 years
or older, diabetes during pregnancy, or are African American, Hispanic/Latino American,
American Indian, Alaska Native, Pacific Islander, or Asian (CDC, 2021). T2DM is often
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accompanied by other conditions including high blood pressure and mixed hyperlipidemia, which
in combination increases the risk for cardiovascular disease, stroke, leg and foot amputations,
and even early death (CDC, 2021).
T2DM can be effectively treated with medication and behavioral lifestyle modifications.
Even small improvements in glycemic control can reduce the risk for debilitating complications
such as heart disease, stroke, kidney disease, sepsis, and retinopathy (Wang et al., 2021,
Haider et al., 2019). Studies have shown that reductions in HbA1c were associated with a 21%
reduction in the risk of diabetes-related deaths (Trevisan et al., 2020). Despite compelling
evidence about the effectiveness of oral anti-diabetic (OAD) medications in combination with
lifestyle changes to improve glucose control, many adults with T2DM are non-adherent to their
treatment regimen (Nelson et al., 2021). Medication nonadherence of OAD medications in T2DM
adult patients ranges from 30-89.9% (Trevisan et al., 2020). Lack of adherence and high rates of
discontinuation of OAD medications have been shown to be contributing factors of uncontrolled
T2DM, classified as HbA1c > 7%.
Medication nonadherence has been a healthcare challenge across the United States,
costing $300 billion annually in the healthcare system (Nelson et al., 2021). Medication
nonadherence is characterized as not consuming a prescribed medication at the correct dose or
at the correct time. Nonadherence can be intentional or unintentional. Intentional non-adherence
is illustrated as patients deciding to take less of their prescribed medication or miss a dose or a
day of their medications; whereas unintentional nonadherence is referred to when patients do not
take their medications as prescribed because they forget or misunderstood the directions of
when and how to take their medications (Kassavou, 2020). Low levels of medication adherence,
or suboptimal adherence is defined as taking medications less than 80% of the days covered
(Zomahoun et al., 2016). Evidence has shown that suboptimal adherence to OAD medications is
associated with higher risks of hospitalizations, financial burden to patients and family members,
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and life-threatening health consequences (Zomahoun et al., 2016, Haider et al., 2019, & Nelson
et al., 2021).
Data Supporting Need for the Project
Global, National, Regional, and State Data
Globally, the prevalence of T2DM in adults in 2040 is projected to be 10.4% because of
the rising aging population, sedentary lifestyle, and obesity contributing to an increased morbidity
and mortality worldwide (Haider et al., 2019 & Sarayani et al., 2019). According to the World
Health Organization (WHO) and the International Diabetes Federation, the global prevalence of
adults aged 20-79 years old with T2DM was “8.5% in 2014”, with 75% of the people residing in
developing countries (CDC, 2021). The CDC National Diabetes Statistics Report from 2017
estimated that 30.3 million Americans have T2DM; of those, 7.2 million people have been
undiagnosed (CDC, 2021). Diabetes is the seventh leading cause of death in the nation, and has
a high correlation to cardiovascular disease and stroke deaths, accounting for more than 79,000
deaths annually (United Health Foundation [UHF], 2021). Populations in the US that are more
affected by diabetes include a) men; b) American Indian/Alaska Native adults; c) adults with less
than a high school education; d) adults with income less than $25,000; and e) older adults (UHF,
2021). The rate of new cases of diagnosed diabetes are estimated to be higher among adults
aged 45-64 years old compared to adults aged 18-44 years old (CDC, 2021).
Indiana ranks 36th in the US for prevalence of DM as shown in the UHF’s America’s
Health Rankings (CDC, 2021). The percentage of adults aged 18 years or older with T2DM
diagnosis in Indiana was 10.4% in 2016 (CDC, 2021). Indiana’s obesity rate is higher than the
national average, with 35% of adults in Indiana being classified as obese compared to 31%
nationally (CDC, 2021). There is a positive correlation between rates of obesity and T2DM in
Indiana. The annual report from 2020 in Indiana displayed a 9% increase in obesity in adults
between 2016 and 2019 from 32.5% to 35.3%. Consequently, adults with diabetes increased
22% between 2011 and 2019 from 10.2% to 12.4% (UHF, 2021).
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Having a diagnosis of T2DM is costly. In 2012, adults with diabetes spent an estimated
average of $13,700 for the year of total medical expenses (CDC, 2021). Additionally, in 2017,
diabetes and its related complications accounted for $327 billion in direct and indirect medical
costs and lost work and wages in the US (CDC, 2021). Thus, the burden of increased healthcare
costs and co-morbid complications related to T2DM can be minimized by improved medication
adherence (Kassavou, 2020).
Clinical Agency Data
The facility where this evidence-based project (EBP) was conducted is a direct primary
care (DPC) health and wellness center in Northwest Indiana. This wellness center is part of a
larger organization, with 60 wellness centers throughout Indiana, Illinois, South Carolina, Texas,
and New Mexico. The DPC model covers most primary care services including clinical,
laboratory, prescriptive medications, and consultative services, as well as care coordination and
comprehensive care management. The clinic consists of a family nurse practitioner (FNP), a
registered nurse (RN), and a certified medical assistant (CMA). The ages treated in the clinic
ranges from pediatrics to adults, and serves a diverse group of patients consisting of African
Americans, Hispanics, Asians, and Caucasians (personal communication, May 25, 2021). In the
summer of 2021, patients resumed seeing the FNP at the wellness center after several months
of staying quarantined during the COVID-19 pandemic. The FNP noticed a trend of patients
complaining of increased weight gain during the pandemic, and patients with T2DM prescribed
two or more OADs had HbA1c’s greater than 7% (personal communication, May 28, 2021). The
wellness center carries several OAD medications that are provided to the patient free of cost
under the DPC model. Patients can receive 3 months-worth of medications at a time and are
able to request refills at the end of their third month. One of the staff members noticed that
patients were requesting medications to be refilled, but not picking up their medications until
weeks later after being reminded by phone call that they have medications ready for pick up at
the clinic (personal communication, July 22, 2021). Metformin, which is often the first-line
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medication used as oral treatment for T2DM was among those chronic medications not being
picked up demonstrating noncompliance with T2DM medication regimen with patients in this
practice. If diabetic patients were not picking up their medications at the clinic and not getting
medications at an outside pharmacy, then it could be assumed that patients are not adhering to
their prescribed medication regimen if their glucose levels are still not in control (personal
communication, July 22, 2021).
Moreover, the organization does not have a set protocol or program in place for
educating patients on the importance of adhering to their treatment regimen. Each provider has
their own verbiage when educating patients on lifestyle modifications related to the diagnosis and
treatment of T2DM (personal communication, June 2, 2021). Education on the diagnosis of
T2DM and the importance of keeping stable glucose levels to avoid the risk of complications may
need to be reinforced during office visits. Additionally, counseling on signs and symptoms of
hypo and hyperglycemia, and how to intervene if experiencing any of the symptoms are some of
the important topics of discussion during the office visit. Under the DPC model, patients are
scheduled for 30–45-minute blocks with the FNP, or 60 minutes if needed for special
circumstances such as a need for more patient education. Although provider visits are longer,
patient counseling on diet and exercise may be overwhelming to hear all in one visit (personal
communication, June 2, 2021). Based on the patient’s increased BMI and report of not taking
medications as prescribed, it was determined that there was a need for an intervention to
improve medication adherence and lifestyle changes in T2DM patients in this clinical practice.
Purpose of the Evidence-Based Practice Project
Purpose Statement and PICOT Question
The purpose of the EBP project was to identify the most effective intervention for
improving medication adherence and lifestyle changes in T2DM patients. Specifically, this project
will address the following PICOT question: In adult non-insulin dependent T2DM patients (P),
does text messaging reminders (I) compared to no text messaging reminders (C) effectively
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improve medication adherence, lifestyle changes, and decrease hemoglobin A1C (O) over a 12week period (T)?
EBP Project Description
The literature supports tailoring daily text messages to individuals to improve medication
adherence and treatment regimen with T2DM patients (Haider et al., 2019, Kassavou et al.,
2020, & Nelson et al., 2021). Patients with a diagnosis of T2DM with a HbA1c greater than 7%
and taking one or more OAD medications were recruited to join the EBP project. One daily text
message using the SPRUCE application (app) was sent to individual participants by the FNP.
The SPRUCE app is currently used within the organization for providers to perform virtual visits
with patients and to communicate with other healthcare providers. The app allows for secure
healthcare communication to take place, and disguises the provider’s real phone numbers to
increase confidentiality. The text messages were one-way text message reminders focusing on
taking their OADs daily, diabetic education from the ADA on diet and exercise, and motivational
text messages (see Appendix F). The primary outcome for this EBP project was improvement in
glycemic control measuring the HbA1c at baseline, then again in 3 months to evaluate
improvements from the intervention. The secondary outcome was improvement in medication
adherence and lifestyle changes measured by a pre and post questionnaire, which included the
8-item Morisky Medication Adherence (MMAS-8) scale and two Likert scale questions focusing
on diet and exercise (Morisky et al., 2008).
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CHAPTER 2
EBP MODEL AND REVIEW OF LITERATURE
Evidence-based Practice Model
Overview of EBP Model
The revised Iowa Model of evidence-based practice guided this EBP project. Six steps
listed in the revised Iowa Model provided a guide for developing, implementing, and evaluating
the EBP project. The revised Iowa Model encourages a collaborative approach and considers
the entire healthcare system, which includes healthcare providers, patients, and the clinical
setting, while using research within these contexts to guide the implementation of research into
clinical practice (Melnyk & Fineout-Overholt, 2019). The revised Iowa Model was chosen
because of its straightforward and easy-to-navigate algorithm, which contains decision points to
analyze if the topic is a priority, if there is sufficient evidence, and if the change is appropriate to
adopt and be sustainable within an organization. The revised Iowa Model requires key
stakeholders to identify the importance of the topic to the organization before initiating the
implementation of change (Melnyk & Fineout-Overholt, 2019).
The first step in the revised IOWA model is identifying a trigger or clinical problem.
Medication nonadherence to OAD medications in T2DM patients was the problem-focused
trigger or clinical problem. The second step is forming a team. A team of key stakeholders
consisting of the FNP, RN, CMA, physician, patients at the clinical site, and the informational
technology (IT) team was formed to help retrieve site data related to medication nonadherence.
The third step is assembling relevant research from databases such as Joanna Briggs Institute
(JBI), Cochrane Library, Turning Research Into Practice (TRIP), Cumulative Index of Nursing
and Allied Health (CINAHL), and Medline. Once the pieces of evidence were collected, appraisal
of each piece was performed using the Critical Appraisals Skills Programme (CASP) tool for
randomized controlled trials (RCT) and systematic reviews (SR) to critique and synthesize the
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evidence, which is the fourth step. An intervention to improve medication adherence in T2DM
patients was developed, using tailored text messages. The fifth step in the revised Iowa Model is
to pilot the change in practice. The intervention was implemented and evaluated during the Fall
2021 and Spring 2022 semesters. Lastly, evaluating the outcomes and assessing if the daily text
messaging intervention can be sustainable in practice to improve patient outcomes is the last
step in the revised Iowa Model. The revised Iowa Model was chosen to be used at the EBP
practice site because the model can be used to effectively implement a practice change to
improve patient outcomes and overall healthcare costs.
Literature Search
Sources Examined for Relevant Evidence
An exhaustive literature search was conducted within the electronic databases of JBI,
Cochrane Library, TRIP, CINAHL, and Medline. Initial searches included several variances of
keywords to reach a suitable relevant evidence search. The following keywords, phrases,
Boolean Operators, and truncation options were used in different combinations to retrieve the
best evidence within each respective database: (“Type 2 Diabetes Mellitus'' OR “Diabetes
Mellitus, Type 2” OR diabetes) AND (MM “Medication Compliance” OR MM “Medication
Adherence” OR “medication compliance” OR “medication adherence” OR MeSH descriptor
[Medication Adherence]) AND interven*. Limiters used in databases included the English
language, publication dates from 2016-2021 or past 5 years, and searching for articles published
in scholarly peer-reviewed journals.
For this review, the inclusion criteria for the pieces of evidence selected were adults aged
18 to 65 years old, diagnosed with T2DM, taking oral medications for treatment of diabetes, and
evaluating effectiveness of interventions for medication adherence. Additionally, evidence was
included if it was written in English, published within the last 5 years, and was rated as Levels I
or II. Exclusion criteria included systematic protocols, articles that focused on older adults greater
than 65 years old, children, insulin-dependent T2DM, prediabetes and gestational diabetes.
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Using keywords, diabetes AND medication adherence OR medication compliance in JBI, 29
possible sources resulted with a yield of 3 because the other sources did not fit the inclusion
criteria. Citation chasing from an evidence summary (Yimei, 2021) led to the identification of one
SR with meta-analysis (Zomahoun, 2017) which met the inclusion criteria and was kept to
critique. The other 2 pieces of evidence from the yield of 3 were discarded because they did not
fit the inclusion criteria. After scanning titles and abstracts in the Cochrane Library using the
MeSH descriptor [Medication Adherence] AND diabetes, 22 pieces of evidence resulted with a
yield of 3. However, one was excluded because the sample studied older adults 65 and older
versus the inclusion criteria of adults 18-65 years old. The other SR was not focused on
medication adherence and contained exclusion criteria. The SR (Van Driel et al., 2016) was kept
and included in the project even though the study focused on interventions to improve adherence
to lipid-lowering medication.
Since T2DM is a chronic disease needing long-term medication treatment, evidence that
included medication adherence to chronic diseases such as hypertension or hyperlipidemia were
included in the search. In the TRIP database, a limiter of USA guidelines was added to the
search, which yielded 0 pieces of evidence from 81 results. Using MM “Medication Compliance”
AND “Diabetes Mellitus, Type 2” AND interven* in CINAHL resulted in 70 sources, with a yield of
5, which included 4 RCTs (Kassavou et al., 2020, Nelson et al., 2021, Sarayani et al., 2018, and
Trevisan et al., 2020) and 1 SR (Haider et al., 2019). In Medline, MM “Medication Adherence”
AND “Diabetes Mellitus, Type 2” AND interven* keyword combinations were used to result in 103
sources. The relevant evidence discovered in Medline did not fit criteria due to being duplicates
of articles found from CINAHL, and not high-level evidence. Only 1 RCT (Varming et al., 2019)
was chosen to be included in the paper because it met all the inclusion criteria. Use of mobile
apps, text messaging, and short message services (SMS) were noted as a theme throughout the
literature so articles including these interventions in the title or abstract were included in the
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search. See the Literature Search Grid in Appendix B and Figure 1 for a condensed view of the
literature search.
Figure 1
PRISMA Flow Diagram

Identification

Screening

Records identified from*:
JBI (n = 29)
Cochrane (n = 22)
TRIP (n= 81)
CINAHL (n = 70)
MEDLINE (n = 103)
Total databases (n = 5)
Records identified by
citation chasing (n = 1)

Records screened
(n = 15)

Records excluded**
(n = 3)

Reports sought for retrieval
(n = 15)

Reports not retrieved
(n = 0)

Reports assessed for eligibility
(n = 12)

Included

Records removed before
screening:
Duplicate records
removed (n =10)
Records removed for
other reasons (n =294)

Studies included in review
(n = 8)
Reports included in review
(n = 8)

Note. A figure describing the literature search

Reports excluded:
Older adults over 65
years old (n =1)
Varied interventions
unrelated to medication
adherence (n = 1)
Protocol of RCT or pilot
study (n = 1)
Type 1 DM and insulindependent (n = 1)
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Levels of Evidence
The Melnyk and Fineout-Overholt Hierarchy of Evidence was used to level the pieces of
evidence for this EBP project. The Melnyk and Fineout-Overholt Hierarchy of Evidence tool
includes seven levels of evidence ranging from Level I to Level VII. Level I, the top of the
pyramid and the highest level of evidence consists of systematic reviews or meta-analyses.
Level II includes evidence from well-designed randomized controlled trials (RCTs). Level III
encompasses controlled trials without randomization. Level IV includes evidence from controlled
cohort and case-control studies. Level V comprises uncontrolled cohort and case-control studies,
whereas single descriptive or qualitative studies are considered Level VI. Finally, the lowest level
of evidence is Level VII, which is composed of the opinions and guidelines of experts or
authorities (Melynk & Finout-Overholt, 2019).
A total of 8 pieces of evidence were selected to be included in the review of literature of
this EBP project. Among the 8 pieces of evidence, 3 were SRs (Van Driel et al., 2016, Haider et
al., 2019, & Zomahoun et al., 2017) which are considered level 1 evidence and the top of the
hierarchy pyramid providing the highest level of confidence. The other 5 pieces of evidence were
RCTs (Nelson et al., 2021, Sarayani et al., 2018, Trevisan et al., 2020, Kassavou et al., 2020, &
Varming et al., 2019). RCTs are level 2 evidence in the hierarchy illustrating a lower risk of bias
and provides the best information about cause-and-effect relationships (Melnyk & FineoutOverholt, 2019). Refer to table 2.1 Summary of Evidence Table.
Analysis and Appraisal of Relevant Evidence
The CASP tool for Systematic Reviews and Randomized Control Trials (CASP, 2020)
tool were used to conduct quality appraisals for the SRs and RCTs. The CASP tool was chosen
because of its bullet-point considerations to prompt thinking when choosing an answer (yes, no,
or can’t tell) for each of the criteria listed on the checklist. Section A in the CASP tool for
appraising RCTs relates to validity, asking if the trial focused on the population studied, the
intervention given, the comparator given, and if outcomes were considered. Other important
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points to consider validity are knowing if the assignment of patients to treatments were
randomized and if all participants who entered the trial were properly accounted for at its
conclusion (CASP, 2020). Likewise, the CASP tool for appraising SRs had questions related to
validity to analyze before moving forward with the rest of the appraisal. The first question asks if
the review addressed a clearly focused question, and the second question asks if the authors
looked for the right type of papers consisting of an appropriate study design and addressing the
review’s question (CASP, 2020). If any of the responses to these questions related to validity
are unclear, then the study is not worth including in the search. This made the appraising
process of each piece of evidence more efficient. In addition to scoring the piece of evidence for
quality, the final consideration is to decide if the interventions could be applicable and
implemented safely in practice, and if the benefits of the outcomes are worth the harms and
costs (CASP, 2020).
The evidence from Van Driel et al. (2016) and Haider et al. (2019) were high quality.
There was minimal bias found in the design, conduct, and analysis of both the systematic
reviews. There were reasonably consistent, generalizable results of the use of digital
interventions for patients with chronic diseases needing long-term medications. The quality of the
evidence from Zomahoun et al. (2017), Sarayani et al. (2018), and Varming et al. (2019) were
moderate. Due to the nature of the intervention, participants were not blind to allocation which
could have led to bias and distortion of the study outcomes. Nelson et al. (2021), Trevisan et al.
(2020), and Kassavou et al. (2020) were high quality evidence pieces. There was true
randomization of participants blinded to the intervention or control group in the trials resulting in
decreased bias. These RCTs also had large sample sizes with low attrition bias. See Appendix
A, the Evidence Synthesis Table with details of each of the pieces of evidence reviewed for this
EBP project.
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Table 1
Summary of Evidence

Author/yr

Zomahoun et al. (2017)

Database(s)

Level of
Evidence/Type

Quality/Tool

JBI

I/SR

Moderate/CASP

Van Driel et al. (2016)

Cochrane

I/SR

High/CASP

Haider et al. (2019)
Nelson et al. (2021)
Sarayani et al. (2018)
Trevisan et al. (2020)
Kassavou et al. (2020)

CINAHL

I/SR
II/RCT
II/RCT
II/RCT
II/RCT

High/CASP
High/CASP
Moderate/CASP
High/CASP
High/CASP

Varming et al. (2019)

MEDLINE

II/RCT

Moderate/CASP

Construction of Evidence-based Practice
Synthesis of Critically Appraised Literature
Throughout the evidence, telecommunication interventions emerged as a low cost and
viable option for improving medication adherence in adults diagnosed with T2DM (Sarayani et
al., 2018, Haider et al., 2019). Telecommunication interventions include the use of telephone,
email, text messaging, and video call. These tools have been used to improve service delivery,
reduce costs, and studies have noted the benefits of mobile phone interventions to improve
diabetes management (Sarayani et al., 2018, Haider et al., 2019). In the United States, 96% of
adults use the text messaging feature on their phones the most because it requires very little
knowledge of technology and is not internet-based. Accumulating evidence has shown that text
messaging interventions can improve medication adherence in patients with chronic diseases,
including T2DM (Nelson et al., 2021, Van Driel et al., 2016, Haider et al., 2019).
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Mobile Phone Text Messages
Mobile phone text messages have been used for appointment reminders, and more
recently, medication reminders to improve medication adherence. However, there were
differences found in the literature in the frequency of sending text messaging reminders and the
type of message content. Text messaging interventions as illustrated in four of the trials in the
SR (Haider et al., 2019) sent three to four messages per week focusing on lifestyle management
including diet, exercise, self-monitoring of blood glucose levels and medication reminders during
a three-to-six-month duration. Five studies sent one or more lifestyle focused text messages per
day, and two studies had a pre-determined and set time for sending medication reminder
messages on a daily basis (Haider et al., 2019). Participants in the RCT (Nelson et al., 2021)
received three types of automated text messages including a one-way text message promoting
self-care, interactive texts about medication adherence, and texts that provided weekly
adherence feedback and encouragement (Nelson et al., 2021).
Although studies have demonstrated a positive impact in medication adherence using a
variation of strategies, daily text messages at every medication dosing time for at least 3 months
were the most common pattern used in the literature and were shown to significantly improve
medication adherence in the short term and after 6 months (Haider et al., 2019, Kassavou et al.,
2020, van Driel et al., 2016). Additionally, studies have demonstrated that lifestyle focused text
messages tailored to the individual were more effective at improving medication adherence and
feasible to obtain clinically meaningful outcomes when compared to the standardized text
(Haider et al., 2019, Kassavou et al., 2020). Examples of tailored text messages include words of
encouragement, brief education on the benefits of proper diet and exercise, or content
specifically from the provider-patient consultation such as habit-forming or self-monitoring advice
(van Driel et al., 2016).
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Motivational Interviewing
Motivational Interviewing (MI) is defined as a collaborative approach between the patient
and provider that aims to strengthen the patient’s motivation and commitment to change
(Zomahoun et al., 2017). Once a trusting relationship is formed between the provider and patient,
they can focus on the goals of the patient and assess the motivation for change. The last step in
MI is developing a plan of action. There are different modes of communication for MI including
face-to-face, phone, internet, written documentation, or group. There were trends found in the
literature that demonstrated MI interventions as an effective method to guide collaboration
between practitioner and patient with setting goals and addressing barriers to self-care, in
addition to improving medication adherence in T2DM patients (Zomahoun et al., 2017, Trevisan
et al., 2020, Van Driel et al., 2016, Varming et al., 2019). Evidence was shown that face-to-face
MI was more effective than a phone call alone (Zomahoun et al., 2017). The intervention group
from the RCT (Trevisan et al., 2020) displayed statistically significant improvements in
medication adherence (p<0.0001) and glycemic control (p<0.0001) when MI is used to enhance
understanding of the goals and strategies to cope with barriers in taking long-term medication
(Trevisan et al., 2020 & Zomahoun et al, 2017). Face-to-face delivery of MI showed a positive
effect in medication adherence with B = 0.192, 95% CI (0.039, 0.344) (Zomahoun et al., 2017).
In the RCT (Varming et al., 2019), participants in the intervention group had four one-onone (in-person) patient-centered diabetic consultations and one telephone follow up call. A faceto-face consultation was done in months one and two, then participants received a phone call to
follow up on goals between the second and third month. In month three, participants had another
face-to-face consultation. The intervention ended after three months, but participants were
followed up in six months with a face-to-face consultation to assess sustainability in the
intervention (Varming et al., 2019). The results of the RCT (Varming et al., 2019) showed no
significant improvements in HbA1C with four additional face-to-face patient-centered diabetic
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consultations in addition to usual care compared to the control group who received usual care
consisting of consultations with nurses, physicians, dieticians, chiropodists, and eye specialists.
Patients need to collaborate with their providers and come up with an action plan
detailing how they intend to adhere to their medications, as well as develop a coping plan with
strategies to address barriers for not adhering to their treatment plan. This collection of data to
tailor text messages may be gained from face-to-face MI during the patients’ regular office visit
rather than having multiple face-to-face diabetes consultations. Furthermore, there was a small
sample size and limited data on MI characteristics such as delivery mode, duration of each
session, number of sessions, and MI training for practitioners resulting in increased bias
(Zomahoun et al., 2017). Sustainability of MI over time was also not studied. Although MI is an
important step to gather vital information on patients’ goals and barriers to medication
adherence, having additional face-to-face consultations was not clinically significant compared to
providing tailored text message reminders after the visit to improve medication adherence.
Outcomes
The primary outcome for all the studies was improvement in glycemic control measuring
the HbA1c at baseline, then again in three months to evaluate improvements from the
intervention. In the SR (Haider et al., 2019), nine out of the eleven studies showed a statistically
significant improvement in HbA1c with educational and motivational text messaging [0.38% (0.53; -0.23, p-value < 0.001)] (Haider et al., 2019). Statistically significant evidence was found in
the RCT (Nelson et al., 2021) of the use of REACH (Rapid Education/Encouragement and
Communications for Health) intervention through mobile phone delivery. Treatment effects on
HbA1c were found at three months (-0.26%; 95% CI -0.48%, -0.05%; p = 0.018) (Nelson et al.,
2021). The evidence from the literature illustrated mobile phone text messaging to be a low cost
but effective digital intervention for improving medication adherence and lowering HbA1c (Nelson
et al., 2021, Kassavou et al., 2020, Van Driel et al., 2016, Haider et al., 2019, & Sarayani et al.,
2018).
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A secondary outcome found in the literature was improvement in medication adherence.
There were differences in how medication adherence that was measured in several of the RCTs,
but patterns in the literature displayed using both the Medication Event Monitoring Systems
(MEMS) and the Medication Adherence Report Scale (MARS-5) or using the MMAS-8 tool by
itself (Zomahoun et al., 2017, Van Driel et al., 2016, Kassavou et al., 2020, and Sarayani et al.,
2018). MEMS is an electronic system that uses microprocessors built into the pill-bottle cap that
registers the date and time of the bottle opening. MEMS, although expensive, provides detailed
and reliable outcome measures with low risk of bias (Van Driel et al., 2016, Zomahoun et al.,
2017, & Kassavou et al., 2020). MARS-5 is an inexpensive tool providing more detail and
differentiation between individuals by assessing adherence, identifying patients reporting low
adherence and the specific types of non-adherence behaviors (intentional versus unintentional).
The MARS-5 tool scores each item on a 5-point scale (5 = never, 4 = rarely, 3 = sometimes, 2 =
often, 1 = very often), rating the frequency of which the five different medication-taking behaviors
occur. The higher the score, the higher the reported adherence (Chan et al., 2019). The MMAS-8
is a low cost, simple, and self-reported tool for assessment of medication adherence to chronic
conditions. There are 8 items on the questionnaire, with questions 1 through 7 requiring “yes” or
“no” responses and item 8 described as a 5-point Likert response. Each “yes” response is rated
as “1” and each “no” is rated as “0”. For item 8, “a never/rarely or 0” response is scored as a “1”
and “all the time or 4” response is scored as a “0”. Responses “1, 2, 3” are respectively rated as
“0.25, 0.75, 0.75.” A score of 8 would mean a high adherence, a score between 6 and 8
indicates medium adherence, and a score of less than 6 would mean low adherence (Okello et
al., 2017).
Recommendation for Best Practice
After a comprehensive literature search and appraising high-level pieces of evidence,
using tailored text messages containing reminders to take their OAD medications, motivational
text messages to focus on diet and exercise, and educational text messages on diabetic
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management were identified as the best practice to improve medication adherence and improve
HbA1c in T2DM patients. Evidence from the literature exhibited lifestyle focused text messaging
tailored to the individual was more effective than the standardized text (Haider et al., 2019).
There were reports on the acceptability of the text messaging intervention with participants
responding that they would recommend this to family members, and that the messages were
reminders to encourage healthy lifestyle (Haider et al., 2019 & Van Driel et al., 2016). There
were no negative outcomes with the use of text messaging reminders found from the studies.
Utilization of text messages is a cost-effective, time-efficient, patient-centered intervention that
can benefit many patients to improve medication adherence and lifestyle changes, and ultimately
decrease the risk of co-morbid complications resulting in uncontrolled T2DM.
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CHAPTER 3
IMPLEMENTATION OF PRACTICE CHANGE
The purpose of the EBP project was to find the best evidence to improve medication
adherence and lifestyle changes in T2DM patients. The synthesis of the literature supported the
cost-effective and patient-centered intervention of sending daily one-way tailored text messages
from medication reminders, diabetic education, motivational texts to improve medication
adherence, lifestyle changes (diet and exercise), and lower HbA1c. This DNP student is also the
NP at the clinical practice site and implemented the practice change in collaboration with the RN
and CMA.
Participants and Setting
Participants that took part of the practice change were patients with a diagnosis of T2DM
with a HbA1c greater than 7%. Other eligible criteria include adults aged 18 to 65 years old,
prescribed one or more OAD medications or injections excluding insulin. Participants of any
gender, race, or socioeconomic background were included in the project. Participants that were
ineligible to participate in the practice change included pregnant women, patients under the age
of 18, insulin-dependent patients, those who do not own a mobile phone, or non-English
speaking patients. There were two nurse practitioners working at the clinical practice site, one
who works full-time during the week and the other NP working part-time on the weekends. The
full-time nurse practitioner at the site who implemented the practice change has been practicing
as an advanced practice nurse for seven years in primary care and thirteen years total in the
nursing field. There were two RNs and one CMA who assisted in calling participants to set up
visits with the NP, collected blood work in the office to assess HbA1c, and triaged participants
during office visits.
The setting for this EBP project was in a DPC wellness center in Northwest Indiana. The
office is open Monday through Saturday with variable hours. The center is open Monday and
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Friday from 7:00 am to 4:00 pm, Tuesday from 6:00 am to 5:00 pm, Wednesday and Thursday
from 7:00 am to 6:00 pm, and Saturday from 7:00 am to 12:00 pm. In addition to the medical
staff and eligible participants at the clinical site, pertinent key stakeholders were the collaborative
physician/clinical advisor, nurse manager, and the IT team.
Pre-Intervention Group Characteristics
Participants were recruited based on a T2DM diagnosis, HbA1c of 7% or greater, adults
aged 18-65 years old, and non-insulin dependent. Participants were recruited in two ways. The
first method was when patients requested medication refills of OAD medications such as
Metformin, the NP flagged the request and performed a chart review in the electronic medical
record (EMR) to search for recent labs done within six months. If there were no labs drawn within
six months, the MA or RN called the patient to schedule fasting labs which included the HbA1c, a
lipid profile, thyroid level, vitamin D, B12, folate, a comprehensive metabolic panel, a complete
blood count, and insulin. The MA or RN also scheduled the patient a week later for a wellness
visit to review labs with the NP. Once lab results returned, the NP reviewed and documented the
interpretation of the labs in the patient’s chart. During the wellness visit and after reviewing the
HbA1c greater than 7%, illustrating uncontrolled T2DM, the NP then explained the purpose of the
EBP project and recruited the patient to be a part of the practice change.
The second method of recruiting participants to join the EBP project was during a
patient’s regular or acute visit to the health center. While the MA or RN triaging the patient were
reviewing the patient’s past medical history, and if there was a diagnosis of T2DM, the staff
notified the NP by adding a comment “**T2DM” in the chief complaint section. The NP then
reviewed the EMR to assess trends of the HbA1c. If there was no recent HbA1c within the last
six months, the RN or MA collected blood work at that visit. If the patient fit the inclusion criteria
of 1) diagnosis of T2DM, 2) on OAD medications or injections, other than insulin, and 3) HbA1c >
7%, then the patient was asked if they would like to participate in the EBP project. At that time,
the patient was given the consent form (see Appendix D) describing the project’s goals and
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expectations, risks, and benefits. Additionally, patients were given a pre-questionnaire
containing the MMAS-8 to assess the type of medication nonadherence, and two Likert scale
questions assessing their current diet and exercise regimen (see Appendix E). Demographics
such as age, gender, and race were found through chart reviews and confirmed on the
questionnaire.
Intervention
Once participants signed the consent form, the NP added the participant’s name and
phone number into the SPRUCE application and sent a text message inviting the participant to
download the free SPRUCE app on their mobile phone. The SPRUCE app is a secure platform
already used among providers within the organization to text, call, or video chat between patients
and providers, or providers to providers. The SPRUCE app disguises the providers’ phone
number to be able to connect with patients without compromising their personal information.
Before participants left the wellness center, the NP asked the participant to send an ‘OK’
message after they received the first welcome greeting text message through the SPRUCE app
to assure that the participant was able to sign in and receive text messages.
Participants included in the EBP project received one daily one-way text message for
twelve weeks consisting of either diabetic education from the ADA, lifestyle focused text
messages encouraging healthy eating habits and exercise, and/or text message reminders to
take their OAD medications (see Appendix F). Through SPRUCE, there was no capability of
sending mass text messages to all the participants at one time, so the NP created daily text
messages, and copied and pasted the message to each of the participants’ SPRUCE account.
In addition to receiving the daily text message intervention, participants also received usual care
for a diabetic patient at the wellness center, which included six month fasting labs, a wellness
visit to review labs with the NP, a complete physical examination, and patient counseling on
healthy diet and exercise recommended by the ADA to improve glycemic control. Specifically,
T2DM patients who were uncontrolled with a HbA1c greater than 7% were recommended to
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increase their current medications or add another OAD medication to their existing medication
treatment plan, and have closer monitoring of the HbA1c every three months until their levels are
less than 7%.
Comparison
Pre-implementation data and post-implementation data were compared. The preimplementation data consisted of a baseline HbA1c and the pre-questionnaire containing MMAS8 questions on medication nonadherence and two Likert-type questions on diet and exercise.
Post-implementation data, which consisted of HbA1c and the post questionnaire containing the
same MMAS-8 and two Likert-type questions on diet and exercise as the pre-questionnaire were
collected after twelve weeks of receiving the daily text message reminders. The questionnaires
were analyzed for improvements in medication adherence and lifestyle changes. A paired t-test
was used to compare pre- and post-intervention MMAS-8 scores to determine if providing daily
and tailored lifestyle text messages will influence medication adherence rates, lifestyle changes,
and decreased HbA1c levels.
Outcomes
The primary outcome for this EBP project was improved glycemic control measured by
the HbA1c. A venipuncture was done, and labs were sent to LabCorp for analysis. Blood work
typically resulted in 1-2 days. A HbA1c was collected at baseline, then again in 3 months after
receiving the text messages. A decreased HbA1c less than 7% shows an improvement in
glycemic control. The secondary outcome for this EBP project was improved medication
adherence by measuring the scores found on the questionnaire at baseline and again in 3
months. The pre and post MMAS-8 scale measures the severity of non-adherence and illustrates
why the patient is not taking their medication. For example, question three on the MMAS-8 scale
asks if participants have ever cut back or stopped taking their OAD medication without telling
their provider, because they felt worse when taking their OAD medication. This type of question
is assessing intentional non-adherence. The MMAS-8 scale has been an established screening
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tool with evidence of validity and reliability in several research for use in chronic conditions
(Morisky et al., 2008). There are 8 items on the questionnaire, with questions 1 through 7
requiring “yes” or “no” responses and item 8 as a 5-point Likert response. Each “yes” response
is rated as “1” and each “no” is rated as “0”. For item 8, “a never/rarely or 0” response is scored
as a “1” and “all the time or 4” response is scored as a “0”. Responses “1, 2, 3” are respectively
rated as “0.25, 0.75, 0.75.” A score of 8 would mean a high adherence, and a score of less than
6 would mean low adherence (Okello et al., 2017). There was one Likert scale question
assessing how often one exercises with responses as a) never/rarely, b) once in a while, c)
sometimes, d) usually, and e) all the time. The last question on the pre and post questionnaires
assessed how participants rated their current diet. The question was formatted in a Likert scale
question with responses as a) not good, b) decent, c) moderate, d) great, and e) excellent (see
Appendix E). The expected outcome in 3 months’ time would be a higher score to show
improved medication adherence. The other secondary outcome would be improved diet and
exercise before and after the text message intervention.
Time
The implementation of the EBP project was a duration of twelve weeks, providing
participants enough time to make therapeutic lifestyle changes (TLC) until their next HbA1c
drawn in three months. The EBP project implementation was divided into three phases: preimplementation, pilot, and evaluation. The pre-implementation phase consisted of talking to
providers within the organization to explore trends of problems found within their practice that
needed change. Improving medication adherence and lifestyle changes (diet and exercise) in
T2DM patients to decrease HbA1c was the priority based on conversations with other providers
and speaking with T2DM patients. The next step was introducing the project and expected
outcomes to key stakeholders. During the summer 2021 semester, the NP reached out to the IT
team within the organization to assist with chart reviews in the new EMR. The organization
switched from one EMR system to another in March 2021 and the transfer of data was still in
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process in the summer months. Some important information such as labs and medications
patients were on did not transfer over to the new EMR. The NP and director of the IT team
provided chart reviews collecting data from the old and new EMR based on eligibility criteria.
Participants that fit the inclusion criteria were documented in a secure spreadsheet with name,
date of birth, last HbA1c date and result, how many OAD medications were listed in their record,
last office visit, and phone number.
Prior to the pilot phase and implementing the EBP practice change, the DNP student
completed the “Social Behavioral Educational Researchers” web-based training and certification
through the Collaborative Institutional Training Initiative (CITI) program. In addition, IRB approval
from both the organization and university were requested and obtained. In the pilot phase,
participants were recruited at the start of the Fall 2021 semester from September to November.
All participants were asked to sign a consent form understanding the EBP project, expected
outcomes, risks and benefits of being in the practice change. Participants were also asked to
download the free SPRUCE application on their mobile phones. At the start of October 2021,
participants started receiving one daily text message reminder to take their medications and/or a
tailored text message focused on healthy eating and encouraging regular exercise. In the
evaluation phase, after 12 weeks, a HbA1c was collected, and participants were scheduled a
follow up visit with the NP to review lab results to assess effectiveness of their 3-month TLC.
Participants were asked to complete the MMAS-8 and Likert-style questions to evaluate
improvement in medication adherence and lifestyle changes. Permission was requested and
granted to use the MMAS-8 tool by the original author, Dr. Morisky during the Spring 2022
semester (see Appendix E). Please see the GANTT chart in appendix C.
Protection of Human Subjects
At the end of the summer 2021 semester, the DNP student received approval from the
Chief Medical Officer of the organization to implement the practice change. IRB approval from
Valparaiso University was also achieved prior to the start of the Fall 2021 semester. In the Spring
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of 2021, the DNP student completed the web-based “Social Behavioral Educational
Researchers” course through CITI to ensure protection of human rights. Participants’ information
was stored in a Microsoft Excel spreadsheet on a private password protected laptop. Anonymity
was maintained by assigning a four-digit numeric code to each participant rather than using
patient identifying information. Data collected was protected to maintain standards of the Health
Insurance Portability and Accountability Act (HIPAA). Questionnaire forms were filed in a locked
cabinet in the provider’s office.
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CHAPTER 4
FINDINGS
The purpose of this EBP project was to implement the best practice to improve
medication adherence, lifestyle changes, and HbA1c in uncontrolled T2DM patients with a
HbA1c greater than 7%. The primary objective was to determine if sending daily one-way text
message reminders to take OAD medications and tailored lifestyle text messages motivating
participants to eat healthy and exercise regularly will decrease their HbA1c over a 12-week
period. Secondary objectives included evaluation of the pre-and post-MMAS-8 scores to assess
medication adherence, and overall participant’s improvement in therapeutic lifestyle changes.
The desired outcome was to have an improved MMAS-8 score, between six to eight showing
medium to high medication adherence, and a lower HbA1c showing improved diabetic
management. Statistical Package for Social Sciences (SPSS-25) was used to perform a
Wilcoxon Signed Ranks matched pairs t-test to show statistical differences between pre-and
post-MMAS-8 scores and pre-and post-HbA1c levels. The Spearman correlation test was
performed to show correlations between the pre-and post-MMAS-8 scores and HbA1c, and lastly
a Kruskal-Wallis test was used to show if diet and exercise played a role in improving HbA1c.
This chapter will present participants’ demographic information and statistical analyses on the
data collected over the 12-week period.
Participants
Sample Size
A total of 24 individuals agreed to participate in the EBP project. They all signed a
consent form to receive daily one-way text messages through the SPRUCE app for 12-weeks.
Participants (n=24) completed the pre-MMAS-8 questionnaire and had their baseline pre-HbA1c
drawn, and agreed to follow up in 12-weeks to complete a post-MMAS-8 questionnaire and have
their blood drawn to collect a post-HbA1c level. At completion of the project, 21 participants had
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completed the 12-week practice change that included a follow up to have their HbA1c level
drawn and completion of the post intervention MMAS-8 questionnaire. Three participants finished
the 12-week practice change, but did not have a follow up appointment soon enough to be
included in the data analysis.
Characteristics. Participants demographic characteristics were analyzed. Participants of
any race, gender, or socioeconomic status were included in the EBP project. Inclusion criteria
included: patients (1) aged 18-65 years old with a diagnosis of T2DM; (2) a HbA1c greater than
7%; and (3) prescribed one or more OAD medications. Exclusion criteria included: patients (1)
under 18 years old; (2) insulin-dependent; (3) unable to speak or understand English; and (4)
does not own a mobile phone or have access to email. There were equal males (50%) to
females (50%) who participated in the EBP practice change (Table 4.1). The ages of the
participants ranged between 28 to 65 years old. The average age of the participants was 52.33
(SD = 9.319). More than half of the participants were Caucasian (52%) and Hispanic individuals
made up 24% of the population. African American individuals made up 16% of the population,
and only 4% of the population was Asian. The minimum number of OAD medications participants
were prescribed was one OAD medication and the maximum number of OAD medications
prescribed was four. The mean number of OAD medications was 1.75 (SD = .737). Participants’
pre-HbA1c ranged from 7% to 11%, with a mean of 8.38 (SD = 1.391). The scoring for the preMMAS-8 scores ranged from 1.5 to 8, with mean of 5.77 (SD = 2.32). Descriptive statistics of the
demographic data are presented in Table 2.
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Table 2
Demographic Characteristics

Demographic

Frequency (%)

Number of participants at commencement

24 (100%)

Number of participants at completion

21 (87.5%)

Attrition

3 (12.5%)

Age
Mean/SD

52.33/9.319

Range

28-65

Gender
Male

12 (50%)

Female

12 (50%)

Race
Caucasian

13 (52%)

African American

4 (16%)

Asian

1 (4%)

Hispanic

6 (24%)

Number of OAD Medications
Mean/SD

1.75/0.737

Range

1-4

Pre-HbA1c
Mean/SD

8.38/1.391

Range

7-11
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Pre-MMAS-8 score
Mean/SD

5.7708/2.32650

Range

1.50 – 8

Changes in Outcomes
This EBP project addressed the following PICOT question: in adult non-insulin dependent
T2DM patients (P), does text messaging reminders (I) compared to no text messaging reminders
(C) effectively improve medication adherence, lifestyle changes, and decrease hemoglobin A1C
(O) over a 12-week period (T)? The primary outcome for this EBP project was improved glycemic
control measured by the HbA1c. A HbA1c was collected at baseline, then again in 3 months after
receiving daily text message reminders. A decreased HbA1c shows an improvement in glycemic
control. The secondary outcome for this EBP project was improved medication adherence by
measuring the scores found on the MMAS-8 questionnaire at baseline and again in 3 months.
Statistical Testing and Significance
The SPSS 25 system was used for data analysis. Cronk (2019) was used as a guide for
data analysis and interpretation. To determine if the EBP practice change was statistically
significant, a non-parametric version of a matched pairs t-test called the Wilcoxon Signed Ranks
test was performed to show significant differences between the pre-and post HbA1c levels and
the pre-and post MMAS-8 scores. To measure the correlation between those participants who
improved in MMAS-8 scores and those who improved in HbA1c levels, a Spearman’s correlation
test was performed. Additionally, a non-parametric version of a one-way ANOVA test called a
Kruskal-Wallis test was performed to measure independent variables such as diet and exercise
and its effect on HbA1c.
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Findings
Primary Outcomes
Improvement in HbA1c. The primary outcome for this EBP project was improved
glycemic control measured by the HbA1c. A HbA1c was collected by venipuncture and sent to
LabCorp for analysis at baseline, then again after completion of the EBP practice change. A
decreased HbA1c less than 7% showed an improvement in glycemic control. Participants’ (n=21)
post-HbA1c ranged from 5.9% to 11.2% with an average of 7.74% (SD = 1.293). Prior to the
practice change, participants’ pre-HbA1c ranged from 7% to 11%, with an average of 8.38% (SD
= 1.391). After performing a Wilcoxon Signed Ranks test, the two-tailed p-value was smaller than
.05 (p-value = .002) suggesting significant evidence to conclude that there was a statistical
difference between pre and post HbA1c levels (Table 3).
Secondary Outcomes
Medication Adherence. The secondary outcome for this EBP project was improved
medication adherence by measuring the MMAS-8 scores found on the questionnaire at baseline
and again after 12 weeks. The pre and post MMAS-8 scale measures the severity of medication
non-adherence and illustrates why the patient is not taking their medication. The MMAS-8 scale
consists of 8 items. Questions 1 through 7 requires a response of either a “yes” or “no.” Each
“yes” response is scored as “1” and each “no” is rated as “0”. For item 8, “a never/rarely or 0”
response is scored as a “1” and “all the time or 4” response is scored as a “0”. Responses “1, 2,
3” are respectively rated as “0.25, 0.75, 0.75.” A score of 8 would translate to a high medication
adherence, a score between 6 to 8 would mean medium adherence, and a score of less than 6
would mean low adherence (Okello et al., 2017). The post-MMAS-8 scores ranged from 2.75 to
8, with an average score of 6.79 (SD = 1.42). At baseline, the pre-MMAS-8 scores ranged from
1.5 to 8, with an average score of 5.77 (SD = 2.32). After performing a Wilcoxon Signed Ranks
test, the two-tailed p-value was smaller than .05 (p-value = .004), this suggests that there was
significant evidence to conclude that there was a statistical difference between pre and post
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MMAS-8 scores (Table 4). To measure the correlation between MMAS-8 scores and HbA1c,
Spearman’s correlation test was performed, which showed a weak positive correlation between
those who improved in MMAS-8 scores and those who improved in HbA1c levels. The weak
positive correlation means that as improvement in MMAS-8 scores increased, the improvement
in HbA1c levels increased, however, the result was not statistically significant (p-value = .575)
(Figure 2). At the completion of the EBP practice change, participants made anecdotal
comments that can provide evidence of clinical significance. One participant said, “I miss
receiving your daily text message reminders to take my medication, all your messages were so
motivating, I have not missed a dose since I stopped receiving your texts.” Another participant
commented, “I thought they (text messages) were good reminders to not forget to take my
medications, I looked forward to receiving the daily text messages. It kept me on track when life
gets busy.”
Therapeutic Lifestyle Changes. Therapeutic lifestyle changes include diet and exercise.
A secondary outcome would be improved diet and exercise after the EBP practice change.
Participants filled out a similar Likert-scale question for diet and exercise. Question 9 in the pre
and post questionnaire assessed how often one exercises with responses as a) never/rarely, b)
once in a while, c) sometimes, d) usually, and e) all the time. Question 10 on the pre and post
questionnaire assessed how participants rated their current diet as a) not good, b) decent, c)
moderate, d) great, and e) excellent. A Kruskal-Wallis test was performed for each independent
variable (diet group vs HbA1c) and (exercise group vs HbA1c). After performing a Kruskal-Wallis
test, the p-value was not significant for the diet lifestyle change in either the pre (p-value = .433)
or the post (p-value = .884). This means that the different levels of diet did not have a significant
difference in HbA1c levels (Table 5). Likewise, using the Kruskal-Wallis test for showing
significance of exercise on HbA1c, the p-value was not significant for the exercise lifestyle
change in either the pre (p-value =.575) or the post (p-value = .367) (Table 6). This means that
the different levels of exercise did not have a significant difference in HbA1c levels.
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Although these findings were not statistically significant, there was a 71.4% increase in
diet and exercise (Figure 3) after the 12-week practice change. Additionally, many anecdotal
comments from participants demonstrated clinical significance. One participant stated during a
follow up visit, “Thank you and I cannot express my gratitude enough for everything you have
done for me. Your guidance has brought me back to a healthy lifestyle.” Another participant
texted in Spruce, “I must say that I find these reminders and messages extremely helpful. The
encouragement I receive is valuable to me. Thank you for all the time you dedicate to fostering
better health for me. My family also appreciates the effort as it does help me share the
information on healthy eating habits and exercise. Thank you and keep it coming!”
Table 3
Pre and Post HbA1c Levels
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Note. The p-value = .002 suggesting significant evidence to conclude that there was a statistical
difference between pre and post HbA1c levels.

Table 4
Pre and Post MMAS-8 Scores

Note. The p-value = .004, this suggests that there was significant evidence to conclude that there
was a statistical difference between pre and post MMAS-8 scores.
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Figure 2
Correlation Between MMAS-8 Scores and HbA1c

Note. The R squared value is .0229. The R-value is .0539 showing a very weak positive
correlation between MMAS-8 scores and HbA1c levels. As MMAS-8 scores improve, HbA1c
levels slightly improve.
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Figure 3
Therapeutic Lifestyle Changes (Diet and Exercise) After Practice Change

Diet & Exercise Improvement Percentage

Increase

Decrease

No Change

Note. There was a 71.4% increase in diet and exercise after the 12-week practice change. 4.8%
decrease in diet and exercise after the 12-week practice change. 23.8% no change in diet and
exercise after the 12-week practice change.
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Table 5
Correlation Between Post-MMAS-8 Scores and Post-HbA1c Levels

Table 6
Diet (Pre and Post) vs HbA1c
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Table 7
Exercise (Pre and Post) vs HbA1c

38

CHAPTER 5
DISCUSSION
The aim of this EBP project was to evaluate the effect of sending daily tailored one-way
text message reminders to T2DM patients to remember to take their OAD medications, focus on
eating a healthy diabetic diet, and exercising regularly. The practice change was implemented
with desired outcomes being improved medication adherence, therapeutic lifestyle changes, and
decreased HbA1c. This chapter will provide an explanation and interpretation of project findings,
strengths, limitations, and sustainability of the project, and future research recommendations.
Explanation of Findings
The statistically significant findings provide supporting evidence for implementation of
sending daily tailored text messaging reminders to take OAD medications and focus on eating
healthy and exercising regularly to improve medication adherence, therapeutic lifestyle changes,
and ultimately lowering HbA1c in T2DM patients. Results from this EBP project were consistent
with current literature regarding best evidence to improve medication adherence and glucose
control in T2DM patients.
Improvement in HbA1c
There was a statistically significant difference in HbA1c from baseline to after the 12week practice change. Mean HbA1c among the 21 participants who completed the 12 week
follow up showed a decrease in HbA1c levels indicating that the daily text message reminders
helped improve medication adherence and lifestyle changes. The minimum HbA1c after the
practice change was 5.9% in comparison to the baseline HbA1c inclusion criteria of 7% or
greater to be included in the practice change. This illustrated better management of diabetes
after the 12 weeks. Findings from the literature showed an improvement in HbA1c after three
months of receiving an intervention to improve HbA1c in T2DM patients which helped to initiate
this evidence-based practice project. In both RCTs reviewed (Sarayani et al., 2017 & Kassavou
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et al., 2020), HbA1c was significantly improved in the intervention group (received a digital
intervention) compared to the control group (received usual care) after three months. In the RCT
(Kassavou et al., 2020), those participants receiving highly tailored text messages for 12 weeks
lowered their HbA1c from an average of 13% to 4.7% (Kassavou et al., 2020). In the RCT
(Nelson et al., 2021), significant treatment effects were found at three months (-0.26%, 95% CI 0.48%, -0.05%, p=0.018) rather than at 12 and 15 months. In the SR (Haider et al., 2019), text
messaging interventions as illustrated in four of the trials sent three to four messages per week
focusing on diet, exercise, self-monitoring of blood sugar levels and cardiovascular risk factor
reduction during a three-to-six-month duration. Nine out of the eleven studies found an overall
reduction in HbA1c of 0.38% (p-value less than 0.001) (Haider et al., 2019).
There were trends found in the literature that demonstrated motivational interviewing
interventions as an effective method to guide collaboration between practitioner and patient with
setting goals and addressing barriers to self-care, in addition to improving medication adherence
in T2DM patients (Zomahoun et al., 2017, Trevisan et al., 2020, Van Driel et al., 2016, Varming
et al., 2019). The SR (Zomahoun et al., 2017), showed positive effects with face-to-face MI in
improving medication adherence in adults with chronic diseases (B =0.192, 95% CI (0.039,
0.344)) (Zomahoun et al., 2017). The positive findings from this project could be attributed to the
motivational interviewing that took place at the initial visit with the NP. At the initial visit, the NP
assessed barriers to medication adherence and lifestyle changes and aimed to strengthen the
patient’s motivation by providing them a three-month therapeutic lifestyle challenge. The
information gathered from the visit were then used to tailor daily text messages to participants.
Medication Adherence
Medication adherence measured by the MMAS-8 scale provided before and after the
practice change showed statistically significant improvements in MMAS-8 scores illustrating
higher medication adherence. The mean post-MMAS-8 score was 6.79 in comparison to the
mean pre-MMAS-8 score of 5.77. This shows that participants had medium to high medication
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adherence after the practice change. Findings in the literature were congruent with the results of
the EBP project in regard to medication adherence. In the RCT (Kassavou et al., 2020), among
nonadherent patients with either or both hypertension and T2DM, a highly tailored digital
intervention was effective at improving treatment adherence and feasible to obtain clinically
meaningful outcomes (Kassavou et al., 2020). As stated earlier in chapter 4, many participants
made positive anecdotal comments regarding the use of daily text message reminders to
improve medication adherence. Providing daily tailored text messages to participants improved
intentional and nonintentional nonadherence. A participant commented on how he remembered
to bring his medications with him on vacation because of the daily text message reminders to
take his OAD medications. The same participant also commented on bringing his workout
clothes with him on vacation to continue exercising regularly.
Therapeutic Lifestyle Changes (Diet and Exercise)
Improvement in TLC (diet and exercise) played a pivotal role in addition to medication
adherence to improve HbA1c. There was a 71.4% increase in diet and exercise after the practice
change showing a positive improvement in lifestyle changes. Before the practice change, 66% of
participants marked their diet as “not good” in the Likert-scale question. After the practice
change, only 9.5% marked their diet as “not good” and almost half of the participants rated their
diet as “moderate.” Likewise, 52% of participants marked “never/rarely” for exercising before the
practice change. After the practice change, 33% of participants marked “once in a while” or
“sometimes” to exercising, which showed an improvement in the number of times participants
exercised per week during and after the practice change. Evidence from the literature exhibited
lifestyle focused text messaging tailored to the individual was more effective than the
standardized text (Haider et al., 2019). Rather than sending automated text messages to
participants with generic information on diet and exercise, the NP tailored the text messages to
focus on participants’ barriers to making lifestyle changes as mentioned during their initial visit.
Examples of text message content included encouraging reminders to exercise, educational
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information on diabetic diet, and reminders to make meals colorful like the rainbow by including
more vegetables and fruits, and less carbohydrates. Text message reminders to meal prep for
the week were regularly sent on Sundays to remind participants to bring a healthy lunch and
snacks to work instead of buying fast food or junk food. All 21 participants who followed up after
12 weeks provided positive feedback, even requesting to continue receiving text messages after
the project.
Strengths and Limitations of the DNP Project
Strengths
There were many strengths of the DNP project. Being the NP at the practice site was an
advantage in recruiting established patients to be a part of the EBP project. Once a good rapport
and mutually trusting relationship was built between the NP and patient, patients were more
motivated to join the EBP project to improve their diabetes. Recruitment took place in the Fall of
2021, during the months of September and October when participants were due for their sixmonth labs and annual physical with the NP. With the help of the IT team, the NP and IT director
were able to scan through the EMR to find patients with a T2DM diagnosis and assess when and
what level their last HbA1c was. The NP was able to reach out to participants who fit the
eligibility criteria by chart reviews to join the EBP project. The clinical practice site’s DPC model
permitting 30–60-minute patient appointments allowed for more motivational interviewing to take
place at the initial visit. The NP was able to collect vital information on participant’s barriers to
medication adherence, lifestyle changes, and assess their motivation to improve their diabetes.
Based on the initial visit, the NP was able to provide tailored text messages to individual
participants based on their own barriers in managing their diabetes effectively. Being able to
tailor text messages to participants made participants feel as if they had their own personal
health coach cheering them on daily to choose the right food options, to prioritize exercise, and
to remember to take their medications. Choosing to use the widely-used valid and reliable
MMAS-8 scale to measure medication nonadherence versus creating a new questionnaire and
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test for validity and reliability saved time in collecting data. Also, having supportive staff (the CMA
and RN) call and follow up on participants to schedule appointments to get their blood drawn
after the 12-week practice change, and performing phlebotomy to collect the HbA1c at the
practice site assured for timely data collection. Furthermore, the SPRUCE app was readily
available to use by the NP to implement the EBP project since the organization already had a
contract with SPRUCE. Advantages to using SPRUCE versus other apps were the ability to
disguise the NP’s personal phone number when sending texts to participants, being able to
schedule text messages to be sent at a specific day and time, and being able to copy and paste
text messages to individual SPRUCE accounts rather than having to type out a text message
individually to each participant. Lastly, another strength of the project was the low attrition
allowing for more statistically significant differences between groups.
Limitations
There were limitations to this project. Since recruitment was done in the Fall of 2021, the
practice change went through Thanksgiving, Christmas, New Years, and for some participants,
Valentine’s Day. Some participants who did not have an improved HbA1c reported that eating
healthy and exercising was challenging during the holidays because of traveling and having
family over for meals. The COVID pandemic also seemed to impact participants’ outcomes.
There were participants who reported having COVID during the practice change and were too ill
to exercise and/or focus on eating healthy and were not taking their OAD medications
appropriately because they were not eating enough. An important theme that was observed in
several participants was depression, playing a role in diabetes. One participant commented after
the practice change that her mood affected how she ate. When her mood was happy, she would
focus more on eating healthy, but when she felt stressed or sad, she would eat more
carbohydrates and sweets to make her feel better. Having untreated or undertreated depression
negatively impacted how participants managed their diabetes. Participants expressed feeling
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overwhelmed by having diabetes and feared the complications of worsening diabetes, yet still
had low motivation to make therapeutic lifestyle changes.
Although the SPRUCE app was readily available to use for the EBP project, the
SPRUCE app also had limitations. A major limitation was not being able to send mass tailored
text messages to participants all at once. This could have been time saving for the NP in regards
to sending daily text messages to participants. Another limitation was not being able to see if the
participant received or read the text message. The text messages were one-way text messages
that were previously established before the start of the project. Being that participants did not
need to reply back, engagement throughout the 12-week period was not monitored. Another
barrier was the collection of data that was set to be completed between January to February, and
into early March. Some participants had to cancel their blood draw and follow up appointments
because the office was closed due to winter storms and unsafe driving conditions. This
consequently led to some challenges in rescheduling those participants in time for the data
analysis. Lastly, participants rated their diet and exercise before and after the practice change by
answering two Likert-type questions. For the exercise question, measurements would have been
more meaningful if each level was categorized as how many times a participant exercised per
week. For example, “once in a while” would be exercising once a week, “sometimes” would be
two or three times a week, “usually” being three to five times a week, and “all the time” being
seven days a week. Additionally, when analyzing data on diet and exercise, variables were not
statistically significant because participants were not equally distributed in each level making the
sample sizes smaller to test for any significant differences between each variable.
Sustainability
The NP met with the IT director towards the end of the practice change to discuss
sustainability of the EBP project. The IT director suggested a new platform called Carium that
allows for real time collaboration between patients and providers. This Carium app has many
features including remote patient monitoring, chronic care management, and health coaching.
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The Carium app can be linked to other apps such as the MyFitness Pal app to record daily food
intake and weight, or the IPhone watch to measure the progress of exercise per week. The
Carium app also can be linked to any cellular or Bluetooth device to track glucose or blood
pressure readings. Rather than waiting three months to assess the HbA1c to evaluate
effectiveness of treatment and make changes to a patient’s treatment plan, use of the Carium
app would be beneficial because providers will be able to see daily glucose logs and determine
sooner if medication changes need to be made. A benefit of using the Carium app instead of
SPRUCE is that the app allows for mass text messages to be sent to patients rather than
individually copying and pasting text messages to each participants’ SPRUCE account. One of
the disadvantages of using the SPRUCE app was not being able to see if the participant read the
message. In the Carium app, providers will not only be able to see if messages were opened and
read, but how the patient is managing their diabetes. Utilization of the Carium app would be a
valuable tool to increase patient engagement and deliver care in a meaningful and proactive
way.
Beneficial changes for implementation of this EBP project in the future would be onemonth check-ins with participants by phone or through Zoom to assess how participants’
therapeutic lifestyle challenge is going, and how they are perceiving the daily text message
reminders. At the one-month check-in, the NP can assess what other barriers participants are
experiencing, for example, participants can be provided with the Patient Health Questionnaire
(PHQ-9) to assess how their depression has been. Another change would be referring
participants to the organization’s health coach for a 60-minute session to assess barriers and
recommendations to improve diet and exercise, and plan development that would allow the NP
to use information from the plan to tailor daily text messages to participants. For a few
participants who did not improve the HbA1c after the practice change, they would be referred to
the health coach for further management of lifestyle changes. The NP will present this practice
change to the organization at one of their weekly clinical management meetings with all the other
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providers working at other wellness centers to assess acceptability of the Carium app part of
their treatment plan for patients with chronic conditions needing long term management.
Relevance for EBP Model
The revised IOWA model for the EBP project was very useful because the steps of the
algorithm were straightforward and easy-to-navigate and allowed for changes to be made
throughout the process if key stakeholders identified an issue to be a priority. For example,
initially the EBP project was focused on just improving medication adherence to OAD
medications, but from gathering data from participants’ pre-MMAS-8 scores, most participants
were taking their medications as prescribed, but had poor diet and exercise. The EBP project
included lifestyle changes to be a secondary outcome in addition to medication adherence
because both medication adherence and lifestyle changes play a large role in managing diabetes
effectively. Text messages were not only daily medication reminders, but focused lifestyle text
messages on healthy eating and prioritizing exercise. The revised IOWA model encourages a
collaborative approach and considers the entire healthcare system, which includes healthcare
providers, patients, and the clinical setting, using research within these contexts to guide the
implementation of research into clinical practice (Melnyk & Fineout-Overholt, 2019). All steps in
the model were necessary to complete the EBP project, particularly, the last step of instituting
the change in practice and considering the environment, staff, cost, patient and family. This
practice change of sending daily text messages to patients who have uncontrolled T2DM, or
even newly diagnosed with T2DM, or any chronic condition where patients are needing to take
long-term medications is a simple, cost-effective, and valuable tool in managing care and
increasing patient engagement with their health.
Recommendations for the Future
This EBP project provided valuable insight in managing T2DM patients in a primary care
setting, with use of a simple and cost-effective method to improve overall patient health and
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wellness. This section will outline future research and education that may effectively guide
evidence-based practice into clinical practice.
Research
Areas of further research were identified during the course of this EBP project. After
hearing some participants openly talk about depression and how their mood negatively impacted
their diabetic management, sparked the spirit of inquiry for this DNP student. Participants dealing
with depression were unable to focus on their health and felt overwhelmed with how to manage
their diabetes. One participant reported difficulty finding the right foods to eat that would not
increase glucose levels. Another participant mentioned stress eating to feel better and requested
resources to find diabetic support groups. More research needs to be done on the correlation
between depression and diabetes, and how to effectively manage both in a primary care setting.
Future projects could be focusing on the effects of support groups for diabetics in improving
HbA1c and lifestyle changes. Further research on the use of the Carium app or any digital app
for patients and providers to continue real life collaboration after the office visit to show how
monitoring glucose logs, food intake, and amount of exercise per week will effectively increase
patient engagement and improve HbA1c. More research is needed to refine whether there is a
best combination of OAD medications to effectively improve different levels of HbA1c, or whether
there are certain OAD medications that should be prescribed for certain individuals. In regards to
TLC, more research is needed to explore best methods of sustaining a healthy diabetic diet and
exercise. For future projects on TLC, it is recommended to use an existing reliable and valid tool
for measuring improvements in diet and exercise. Lastly, it is recommended that future projects
related to improving HbA1c in T2DM patients try to enhance sample size of the project, at least
over 30 participants for more statistical power.
Education
This EBP project has highlighted areas where education is needed for practicing
providers, staff, nursing and medical students. Primary care providers need to understand the
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most common barriers patients are having that are negatively affecting diabetes management.
Staff should be knowledgeable on how to educate patients on how to use their glucometer, as
well as counseling patients on the common signs and symptoms of hypo-and-hyperglycemia,
and what to do when they are having hypoglycemic episodes. Furthermore, patients need to
have more education on the risk for severe complications of T2DM when their glucose is
consistently elevated. Some participants reported prior to the practice change that they did not
fully understand the risk of complications with T2DM, such as having nephropathy, neuropathy,
retinopathy, increased risk for infection, heart disease, and stroke. Some participants reported
because they were not feeling sick or having symptoms of hyperglycemia, they were not taking
their prescribed OAD medications regularly because of the gastrointestinal side effects of
Metformin.
Moreover, providers need to be familiar with the DSM-V criteria for depression and
should regularly assess diabetic patients for depression by providing patients with the PHQ-9. A
score between 15 and 19 on the PHQ-9 would show moderately severe depression indicating
initiation of pharmacotherapy and psychotherapy (MDCalc, 2022). Providers need to be
educated on what the next steps are in treating depression in T2DM patients.
Conclusion
In conclusion, the results of this EBP project showed that sending daily tailored one way
text message reminders to take OAD medications, and motivational text messages focusing on
eating a healthy diabetic diet and exercising regularly significantly improved medication
adherence, lifestyle changes, and HbA1c levels in T2DM patients. Globally, the prevalence of
T2DM in adults in 2040 is projected to be 10.4% because of the aging population, sedentary
lifestyle, and obesity which all will contribute to an increased morbidity and mortality worldwide
(Haider et al., 2019 & Sarayani et al., 2019).
T2DM can be effectively treated with medication and behavioral lifestyle modifications.
Even small improvements in glycemic control can reduce the risk for debilitating complications
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such as heart disease, stroke, kidney disease, sepsis, and retinopathy (Wang et al., 2021,
Haider et al., 2019). Primary care providers are at the forefront of preventing and slowing down
the progression of chronic disease. Therefore, utilization of text messages is a highly acceptable,
cost-effective, time-efficient, patient-centered intervention that can benefit many patients to
improve medication adherence and lifestyle changes, and ultimately decrease the risk of comorbid complications resulting in uncontrolled T2DM. Furthermore, sending tailored text
messages to patients will enhance collaboration between the provider and patient, and most
importantly, improve patient’s overall well-being.
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APPENDIX A
Evidence Synthesis Table

Lead Author/
Year/Quality

Purpose/
Design/Sample

Interventions

Measurement/
Outcomes

Results/
Findings

Strengths/
Limitations

Level I Evidence

Van Driel,
M.L./2016/
High Quality

Purpose: To
evaluate the
effectiveness of
interventions to
improve
medication
adherence to
lipid-lowering
drugs.
Design:
Systematic
Review
Sample: 35
RCTs of adults
over 18 years of
age who were
prescribed lipidlowering
medication for
primary or
secondary
prevention of
cardiovascular

Intensified patient care
intervention involving
electronic reminders,
pharmacist-led
interventions,
education from
healthcare
professionals versus
usual care or no
intervention.
Interventions include:
-“simple drug regimen
-patient education and
information
-increased follow-up,
sending out reminders
-group sessions,
rewards
-computer-based
information systems

“Methods used to
measure adherence
include self-report,
Medication Adherence
Report Scale (MARS),
medication possession
ratio (MPR), proportion
of days covered (PDC),
medication event
monitoring systems
(MEMS), prescription
refill rate, pill count” (p.
11).
Primary outcomes:
Measuring adherence
“Indirect – pill count,
prescription refill rate,
electronic monitoring;
“Subjective – person’s
self-report in diaries,
interviews;

Medication adherence at
less than 6 months between
participants receiving usual
care vs intensified patient
care had 95% CI, OR 1.93
(1.29 to 2.88).

Strengths:
assessed a
wide range of
interventions
for medication
adherence for
lipid-lowering
Greater than 6 months: 95% treatments
CI, OR 2.87 (1.91 to 4.29).
that could also
be
Polypill vs separate dosing
generalized to
regimens resulted in
other chronic
improved adherence.
conditions
Rather than dosing 4 times
needing longa day, switching it to twice
term
daily is preferred.
medication
therapy.
Intensified patient care
interventions including
Low risk of
telephone reminders,
selection,
calendar reminders,
reporting, and
integrated multidisciplinary
attrition bias
educational activities and
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disease in
ambulatory
settings.

Haider,
R./2019/
High Quality

Purpose: To
assess the
effectiveness of
mobile phone
text messaging
in improving
glycemic control
for patients with
Type 2 Diabetes
Mellitus.
Design:
Systematic
Review and
meta-analysis
Sample: 11
RCTs with adult
patients over 18

-audit, documentation,
computers, copayments
-large scale
pharmacy-led
automated telephone
intervention” (p. 6).

“Direct – tracer
substances in blood or
urine” (p. 6).

Text messaging
interventions as
illustrated in 4 of the
trials sent 3-4
messages per week
focusing on diet,
exercise, selfmonitoring of blood
sugar levels and
cardiovascular risk
factor reduction during
3-6 month duration.
5 studies sent one or
more messages per
day.

pharmacist-led interventions
improved medication
adherence in both the short
term (less than 6 months)
and long term (more than 6
months).

across
studies.

Primary outcomes:
improving glycemic
control, measuring
HbA1c in 3 follow up
periods (<3 months, 412 months, and >12
months).

5 studies showed a
significant improvement in
HbA1c with educational and
motivational text
messaging, and the other
studies showed trends of
improvement.

Secondary outcomes:
assessing the
acceptability of mobile
phone interventions
and reduction in
cardiovascular risk
factors.

Strengths:
“All 11 studies
described
random
sequence
generation,
which resulted
in low risk of
bias” (p. 34).

9 out of the 11 studies
found an overall reduction in
HbA1c of 0.38% (-0.53; Limitations:
0.23, p-value less than
Due to the
0.001).
nature of the
intervention,
Lifestyle focused text
blinding was
messaging tailored to the
not done for
the

Secondary outcomes:
“Physiological
indicators: total
cholesterol; health
outcome indications:
quality of life, morbidity,
mortality; adverse
effects; impact of
intervention on
economic outcomes”
(p. 6).

Limitations:
“blinding
participants to
the
intervention
they were
receiving and
blinding
healthcare
providers was
not possible,
given the
nature of the
intervention”
(p.14).
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Zomahoun,
2017/Modera
te Quality

years old with
type 2 DM, with
at least 4 weeks
follow up after
receiving text
message
interventions
designed to
improve diabetes
related
outcomes.
Excluded
participants were
those with Type
1 DM, prediabetes or
gestational
diabetes.

2 studies had a predetermined and set
time for sending
messages on a daily
basis.

Purpose: To
assess if
motivational
interviewing (MI)
is an effective
way to improve
medication
adherence in
adults with
chronic
diseases.
Design:
Systematic

Motivational
interviewing between
practitioners and
patients that aim to
strengthen the
motivation and
commitment to
change.

individual is more effective
than the standardized text.
Only 3 out of the 11 studies
reported on the acceptability
of the text messaging
intervention with
participants responding that
they would recommend it to
family members and that
the messages were
reminders to encourage
healthy lifestyle.
There were no negative
outcomes with these
interventions.

participants in
the
intervention
group in any
of the trials.
RCTs chosen
with
unidirectional
messaging
intervention
which may
have limited
the number of
studies
chosen.

Lifestyle focused text
messaging is low cost and
may act as an adjunct to
standard care.

Different modes of
communication for MI:
face-to-face, phone,
internet, written
documentation, group.

Primary outcome:
increased medication
adherence for chronic
diseases.
Medication adherence
measured in 14 studies
by self-report derived
from the Medication
Event Monitoring
Systems (MEMS).
Used Hedge’s g (a
standardized mean

Although sample size was
small, there were positive
effects with MI face-to-face
and being coached through
the session than just a
phone call alone.
“Face-to-face delivery of MI
showed a positive effect
with B = 0.192, 95% CI
(0.039, 0.344)” (p. 595).

Strengths:
Assessed risk
of bias for
each of the
studies before
including in
the final metaanalysis.
Limitations:
Sample size
small leading
to bias.
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Review and
meta-analysis.
Sample: 19
RCTs with 16
included in the
meta-analysis
with focus on
adults with
chronic diseases
who self-manage
their own
medication
treatment.

Lacking MI
characteristics such
as delivery mode,
duration of each
session, number of
sessions, and MI
training for
practitioners.

difference (SMD) to
measure for small
sample size.

MI was illustrated to be an
effective way for patients to
adhere to their medications.
“The pooled effect size of
MI interventions that was
measured using all 17
studies was 0.23 [95% CI =
(0.08, 0.37), p value =
0.003] (p. 593).

Other delivery
modes such
as face-toface
combined with
phone calls,
group
delivery, or
computerbased delivery
were only
found in 1
study and
therefore, not
analyzed.
Sustainability
of MI over
time was not
studied. More
exploration is
needed to
understand
the behavioral
changes that
result as an
effect of MI on
medication
adherence.

Level II Evidence (use this format to add additional levels as your evidence warrants)

Nelson,
L.A./2021/

Purpose:
“Evaluate two
mobile phone-

REACH participants
received three types
of automated text

Primary outcome:
Hemoglobin A1C
measured at baseline

At 6 months, “the treatment
effect on HbA1c was
greater (-0.31%; 95% CI -

Strengths:
Matched
randomization
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High Quality

delivered
interventions
(REACH [Rapid
Education/Encou
ragement and
Communications
for Health] and
Family-Focused
Add-on for
Motivating SelfCare [FAMS] on
diabetes
outcomes” (p.
27).
Design: RCT
Sample: Half
racial/ethnic
minorities and
half
underinsured,
had annual
household
incomes less
than $35,000,
high school
education or
less. Average
baseline HbA1c
greater than
8.5%. Adult
patients from
primary care
locations in
Vanderbilt
diagnosed with
Type 2 DM.

messages: “self-care
promotion one-way
texts, interactive texts
that asked about
medication
adherence, and
adherence feedback
texts that provided
weekly feedback and
encouragement based
on responses to the
interactive texts” (p.
29).
FAMS was delivered
for the first 6 months
to complement
REACH. It consisted
of monthly phone
coaching to set
diabetes self-care
goals and improve
family/friend
involvement.
“MEMOTEXT, a digital
health platform, used
relevant participant
information transferred
from REDCap
(Research Electronic
Data Capture) via an
application
programming interface
to tailor, schedule, and

and then compared at
3, 6, 12, and 15
months.
Secondary outcome:
“Diabetes medication
adherence measured
by ARMS-D
(Adherence to Refills
and Medications Scale
for Diabetes) and
SDSCA-MS (Summary
of Diabetes Self-Care
Activities medications
subscale” (p. 29).
Tertiary outcome:
Physical activity using
the International
Physical Activity
Questionnaire (PDQ),
and self-efficacy using
the Perceived Diabetes
Self-Management
Scale, 4-item version
(PDSMS-4).

0.61%, -0.02%) than those
with baseline HbA1c greater
than 8.5% (-0.74%; 95% CI
-1.26%, -0.23%)” (p.26).
Significant treatment effects
were found at 3 months (0.26%; 95% CI -0.48%, 0.05%; p = 0.018).
Treatment effects were not
significant at 12 and 15
months.
“REACH improved
medication adherence and
diet through 12 months and
self-efficacy through 6
months” (p. 26).
Participants found the 2way adherence text
messages and associated
feedback messages to be
helpful.

resulted in
strong
balance
across
conditions at
baseline, with
all P values
greater than
0.05.
“Oversamplin
g racial/ethnic
minorities and
patients with
lower
socioeconomi
c status
enhances
generalizabilit
y to adults
with diabetes
at higher risk
for poor
outcomes” (p.
32).
Limitations:
Self-report
measures for
behavioral
outcomes
were subject
to recall and
social
desirability
bias.
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send text messages”
(p.27).
Trevisan,
D.D./2019/
High Quality

Purpose: To
evaluate the
effects of an
implementation
intention
intervention for
medication
adherence to
Type 2 DM
patients taking
oral
hypoglycemics.
Design: Singleblinded RCT with
an IG and CG.
Sample: Adults
diagnosed with
Type 2 DM on
oral
hypoglycemics
for more than 6
months and have
a positive
intention for
taking their
medications.

Intervention group
received an
implementation
intention intervention
consisting of action
and coping plans:
“participants filled out
an action plan of
when, where, and how
they intend to take
their medications over
the next 2 months”
and coping strategies
for obstacles and
barriers to taking their
medication (p. 583).
Control group:
standard care of
traditional office visits
with provider.

Primary outcome:
Increased medication
adherence to oral
hypoglycemics,
decreased hemoglobin
A1C.

IG showed improvements in
medication adherence
(p<0.0001), glycemic control
(p<0.0001), and diabetes
related distress (p<0.0001).

Collaboration between
Medication adherence
patient and practitioner is
measured by use of the increased when both parties
Instrument for the
understand the goals and
Global Evaluation of
strategies to cope with
Medication Adherence barriers in taking long term
(IAGAM). Patients
medication. This is a low
reporting taking
cost intervention to improve
medication more than
DRD and HbA1C.
80% of the time and
exercising appropriate
care were deemed
“adherent.”
HbA1C measured at
baseline then again in
15 weeks.
Secondary outcome:
diabetes related
distress (DRD) and
intention to adhere to
medications.
DRD measured using
the 17-item Diabetes
Distress Scale

Strengths:
True
randomization
and blinding
of participants
to IG and CG
decreasing
risk of bias.
Sample size
sufficient to
assess
primary
outcomes.
Limitations:
Inclusion
criteria did not
include a
minimum
HbA1C level
at baseline.
Useful to have
followed
patients for a
longer time to
assess long
term impact
on HbA1C.
Self-reports
for adherence
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which is
subjective
data versus
objective.
Further
research is
needed to
assess
objective data
on medication
adherence.

Intention was
measured using Likert
scale (1, absolutely not
to 5, very likely).

Kassavou,
2020/High
Quality

Purpose: Aims to
assess
behavioral
change to
medication
adherence using
a highly tailored
digital
intervention to
improve
outcomes in
patients with
HTN or Type 2
DM. Design:
RCT of 2
paralleled
groups.
Sample: 135
nonadherent
patients greater
than 50 years old
with either or
both HTN and
Type 2 DM.

IG received highly
tailored text messages
and interactive voice
response intervention
for 12 weeks as an
adjunct to usual care.
Patients were able to
tailor how many
messages they
wanted to receive
each week.
CG received usual
care of traditional
office visits with their
provider.

Primary outcomes were
the efficacy of the
intervention to support
medication adherence,
measured using 2 selfreported items of
adherence.
Secondary outcomes
include the
mechanisms used as
interventions for
medication adherence,
satisfaction and
engagement of the
intervention.
The Medication Event
Monitoring System is
an electronic pill-bottle
cap that registers the
date and time of the
bottle opening. This
was given to

Medication adherence was
significantly improved in the
intervention group
compared with the
control group (P =.02, 2tailed). Systolic blood
pressure was 0.6 mmHg
(95% CI −7.423 to 6.301),
and hemoglobin
was 4.5 mmol/mol (95% CI
−13.099 to 4.710) lower in
the
intervention group
compared with the control
group.
Among nonadherent
patients with either or both
hypertension
and type 2 diabetes, a
highly tailored digital
intervention was
effective at improving
treatment adherence and

Strengths:
Attrition rate
was low.
Engagement
and
satisfaction
were high.
Recruitment
was high.
Patients were
recruited from
a range of
primary care
practices,
most in
deprived
areas,
scalable.

Limitations:
Could not
reliably
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participants in the IG
for 7 consecutive days
to measure the
mechanism used for
medication adherence.

feasible to obtain
clinically meaningful
outcomes.
Intervention was effective
at improving medication
adherence by supporting
intentional and
nonintentional
nonadherence.

identify the
patterns of
nonadherent
behavior or
identify the
frequency of
changes in
medications.

Low cost for digital
intervention, effective
intervention as an adjunct to
usual care.
Sarayani,
2017/
Moderate
Quality

Purpose: To
evaluate the
effectiveness of
a telephonebased
intervention
provided by a
pharmacist in
improving care
and clinical
outcomes in the
short- and longterm care for
Type 2 DM
patients.
Design: 2-armed
parallel group
RCT with 1:1
allocation ratio.

IG: Received 16
telephone calls in 3
months by a trained
pharmacist.

Primary outcome:
Improvement in HbA1C

Medication adherence and
self-care significantly
improved with the IG after 3
months.

Strengths:
Use of a
balanced
Measured at baseline,
block
3 months (after
randomization
2 calls/week x 1
intervention), then in 9
Telephone follow ups after a method to
month, 1 call/week x
months (follow-up).
live educational session in 3 generate
2-3 months.
or 9 months may improve
random
Pharmacists had a
Secondary outcomes:
medication adherence.
allocation
checklist to review and Changes to lipid profile,
sequence.
reinforce diabetes
medication adherence
HbA1C was significantly
education from live
measured using the 8- improved in both IG and CG Limitations:
seminar prior to
item Morisky
at month 3 (6.97+or -1.41 vs Due to the
recruitment of
Medication Adherence 7.09+or-1.78).
nature of the
participants into the
questionnaire by phone
study
study.
interview and self-care
intervention,
measured by Self-care
blinding of
CG: received usual
Activities Measure
participants
care.
questionnaire by phone
was not
interview.
performed.
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Sample: 100
patients with
Type 2 DM with
HbA1C greater
than 7%, on oral
diabetic
medications.
Varming,
2019/
Moderate
Quality

Purpose: To
examine whether
patient centered
consultations
improves
glycemic control
and selfmanagement
skills in
uncontrolled
Type 2 DM
patients.
Design: RCT
Sample: 97
adults diagnosed
with Type 2 DM
for more than 1
year with levels
of Hemoglobin
A1C greater than
8%.

Intervention group:
patient-centered
diabetes consultations
using the EMMA
(empowerment,
motivation, medication
adherence)
framework.

Primary outcome:
HbA1C, BMI, BP

4 one-on-one (inperson) consultations
and 1 telephone follow
up call. “Dialogue
tools consist of
images, quotes,
questions, illustrations
and worksheets to
facilitate learning and
goal setting” (p. 2239).

Outcomes assessed at
baseline, after
intervention, and 6
months after for follow
up.

Face-to-face
consultations with
providers on months 1
and 2, then phone
call, and another faceto-face on month 3,
then follow up in 6
months.

Secondary outcome:
Autonomy support,
motivation, selfmanagement skills, and
well-being.

Secondary outcomes
measured by 6
questionnaires: “Health
Care Climate
Questionnaire (HCCQ),
Treatment SelfRegulation
Questionnaire (TSRQ),
Perceived Competence
in Diabetes (PCD),
Summary of Diabetes
Self Care Activities
(SDSCA), WHO-5, and

EMMA was not superior to
usual care as far as
decreasing HbA1C.
EMMA is an effective
framework to guide
collaboration between
practitioner and patient with
setting goals and
addressing barriers to selfcare.

Strengths:
Randomized
design,
inclusion of
unique study
group for a
long duration
of time.

Limitations:
Differences in
baseline
Medication adherence was
characteristic
high in comparison to
data for the
lifestyle challenges of losing groups may
weight, eating a healthier
have affected
diet, and increasing physical the results.
activity.
Intervention
and follow up
time may
have been too
short to see
significant
changes in
HbA1C.
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Control group: usual
care consisting of
consultations with
nurses, physicians,
dieticians,
chiropodists, and eye
specialists. Time
frame varies per
individual.

Problem Areas in
Diabetes (PAID-5)”
(p.2240).
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APPENDIX B

Literature Search Grid

Database/Resource
Searched

Keywords/Phrases

Limiters

Used

Used

Number of
Results

Number of Pieces of
Evidence Selected for
Use

from Search
In Paper
CINAHL

(MM “Medication Compliance”)
AND “Diabetes Mellitus, Type 2”
AND interven*

English language,
published dates 20162021, scholarly (peer
reviewed) journals

70

5

Cochrane

MeSH descriptor: [Medication
Adherence] AND diabetes

publication dates
2016-2021

22

1

JBI

Diabetes AND medication
adherence OR medication
compliance

English language and
publication dates from
2016-2021 (past 5
years)

29

0

66

Medline

(MM “Medication Adherence”)
AND “Diabetes Mellitus, Type 2”
AND interven*

English language and
publication dates from
January 2016 to June
2021, scholarly peer
reviewed journals

103

1 (many duplicates of
studies found from
other databases)

TRIP

(“Type 2 Diabetes Mellitus”) AND
(“medication compliance” OR
“medication adherence”)

USA guidelines, Since
2016

81

0

Number of
Pieces
Searched

Number of New Pieces
of “Chased” Evidence

List the Title of the Article/Original
Piece of Evidence that contained
the “Citations Chased”
Pieces of Evidence
selected that were
“Citation Chased”
from systematic
reviews, evidence
summaries,
guidelines, etc.

Selected for Use
N/A

Medication Adherence in Chronic
Illness: Motivational Interviewing
(MI)

N/A

1

1

List the Title of each of the
Journal(s)

List the Years/Time
Frame that was
Searched

Number of
Pieces
Evaluated

Number of New Pieces
from “Hand
Searching”

that were “Hand Searched”

67

Selected for Use

Pieces of Evidence
selected that were
“Hand Searched”
from the table of
contents of specific
journals

Total
Number of
pieces of
Evidence
Identified for
Use:

8
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Appendix C
Gantt Chart
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Appendix D
Patient Consent Form

Title of Evidence Based Practice Project (EBP)
The Efficacy of Tailored Text Messages to Improve Medication Adherence and Lifestyle
Changes in Patients with Type 2 Diabetes Mellitus
Principal Investigator
Vanessa Silverio, Family Nurse Practitioner, Post-Master’s DNP Student - Valparaiso
University
vanessa.silverio@valpo.edu
Faculty Supervisor
Scarlet Spain, DNP
Purpose of EBP Project
You are being asked to take part in an evidence-based practice (EBP) project. Before
you decide to participate, it is important that you understand why this EBP project is
being done and what it will involve. Please read the following information carefully.
Please ask the principal investigator if there is anything that is not clear or if you need
more information.
The purpose of this EBP project is to determine a cost-effective and efficient intervention
for improving medication adherence in patients with Type 2 Diabetes Mellitus (T2DM).
Interventions have been selected based on the best available evidence.
Project Procedures
During appointments at the health and wellness center, the principal investigator will
determine if you are eligible to participate in the practice change. Adults between the
ages of 18-65 years old, with diagnosis of T2DM, on oral anti-diabetic medications
(OADs), and with a hemoglobin A1C greater than 7%. During your first visit with the
nurse practitioner, you will be asked to fill out a questionnaire about medication
adherence, diet and exercise, and again after 12 weeks to see if there has been any
improvement after receiving daily medication reminders and lifestyle focused text
messages on healthy eating habits, exercise, and/or topics discussed during your oneon-one session with the nurse practitioner. You will have to download the free secure
SPRUCE application on your mobile phone in order to receive text messages. This EBP
project will last approximately 12 weeks.
Risks
There are no potential risks for participating in this EBP project. The SPRUCE app is a
secure platform to communicate with the nurse practitioner, all of the information shared
with the provider will be private and follow HIPPA guidelines.
Benefits
There are multiple benefits of participating in this EBP project. You will be receiving daily
text message reminders to take your medications at the right dose and at the right time.
Additionally, you will be receiving tailored text messages to remind you of healthy eating
habits, increasing exercise, strategies to improve medication adherence to ultimately
improve glycemic control of your diabetes. These simple interventions are based on
recommendations from the best available evidence. The goals of using text messaging
reminders for medications and lifestyle changes is to improve glycemic control while
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being cost-effective. The results from this EBP project may help to advance nursing
practice and knowledge as well, in addition to implementing the intervention to other
health and wellness centers within the organization.
Confidentiality
All efforts will be made by the primary investigator to keep your personal information
confidential. All records containing your personal information will be kept in a locked box
with access permitted only to the primary investigator. To further increase confidentiality,
a code will be assigned to you for your questionnaire forms. Any information stored on a
computer will be password protected and accessed only by the primary investigator.
Contact Information
If you have any questions at any time about this EBP project, or you experience adverse
effects as the result of participating in this EBP project, you may contact the primary
investigator who contact information is provided on the first page. If you have any
questions regarding your rights as a project participant, or if problems arise which you do
not feel you can discuss with the primary investigator, please contact the Valparaiso
University Institutional Review Board at valpoirb@valpo.edu or 219-464-5798.
Voluntary Participation
Your participation in this EBP project is voluntary. It is up to you to decide whether or not
to take part in this project. If you decide to take part in this EBP project, you will be asked
to sign a consent form. After you sign the consent form, you are still free to withdraw at
any time and without giving a reason. Withdrawing from this EBP project will not affect
the relationship you have, if any, with the health care provider or staff at the wellness
center. If you withdraw from the EBP project before data collection is completed, your
data will be destroyed.
You may decline to answer any or all questions and you may terminate your involvement
at any time if you choose.

I have read and I understand the provided information and have had the opportunity to
ask questions. I understand that my participation is voluntary and that I am free to
withdraw at any time, without giving a reason and without cost. I understand that I will be
given a copy of this consent form. I voluntarily agree to take part in this EBP project.
Participant’s Signature _________________________________Date ______________
Investigator’s Signature ________________________________Date ______________
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Appendix E

Certificate Number: 1757-3241-9673-6680-7920

MMAS ENTITLEMENT CERTIFICATE
This certificate evidences the Morisky Medication Adherence Research, LLC grant to
customer of licenses for the following purchase. The product(s) listed below include single
license study, as such term is defined in the MMAS License Agreement, for an initial license
period. In order to obtain MMAS License Studies for any subsequent license, you will need
to purchase an additional license from Morisky Medication Adherence Research, LLC.

Product

Description

MMAS-8

“The Efficacy of Tailored Text Messages to Improve
Medication Adherence and Lifestyle Changes in
Patients with Type 2 Diabetes Mellitus

Customer Information:
Vanessa Silverio, MSN, FNP-C
Valparaiso University, Valparaiso, Indiana

www.moriskyscale.com

Quantity
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Appendix F
Medication Adherence and Lifestyle Questions
The Efficacy of Tailored Text Messages to Improve Medication Adherence and Lifestyle
Changes in Patients with Type 2 Diabetes Mellitus
Pre/post-questionnaire
Age _________Gender ________
Race: White ____ African American _______Asian ______Hispanic _______ Other _________
Number of oral anti-diabetic (OAD) medications currently taking ______________
PreHbA1C ___________ Post HbA1C _____________
(© 2006 Donald E. Morisky)

1. Do you sometimes forget to take your oral anti-diabetic (OAD) medications?
No_______ Yes_______
2. Thinking over the last 2 weeks, were there any days when you did not take your OAD
medicine?
No_______ Yes_______
3. Have you ever cut back or stopped taking your medication without telling your provider,
because of the side effects causing you to feel worse?
No_______ Yes_______
4. When you travel or leave home, do you sometimes forget to bring along your OAD
medication?
No_______ Yes_______
5. Did you take your OAD medicine yesterday?
No_______ Yes_______
6. When you feel like your diabetes is under control, do you sometimes stop taking your
medicine?
No_______ Yes_______
7. Do you ever feel annoyed about sticking to your diabetic treatment plan?
No_______ Yes_______
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8. How often do you have difficulty remembering to take all your medications?
a. Never/rarely _______________
b. Once in awhile _________________
c. Sometimes_________________
d. Usually _________________
e. All the time_______________
9. How would you rate how often you exercise per week?
a. Never/rarely _______________
b. Once in awhile _________________
c. Sometimes _________________
d. Usually_________________
e. All the time _______________
10. How would you rate your current diet?
a. Not good _______________
b. Decent _________________
c. Moderate _________________
d. Great _________________
e. Excellent _______________
The MMAS-8 Scale, content, name, and trademarks are protected by US copyright and
trademark laws. Permission for use of the scale and its coding is required. A license
agreement is available from MMAR, LLC., Donald E. Morisky, ScD, ScM, MSPH, 294
Lindura Ct., USA; donald.morisky@moriskyscale.com.
Morisky, D.E., Ang, A., Krousel-Wood, M., & Ward, H. (2008). Predictive Validity of a Medication
Adherence Measure for Hypertension Control. Journal of Clinical Hypertension 10(5): 348-354.
Berlowitz DR, Foy CG, Kazis LE, Bolin L, Conroy LB, Fitzpatrick P, et al. for the SPRINT Study Research
Group. Impact of Intensive Blood Pressure Therapy on Patient-Reported Outcomes: Outcomes
Results from the SPRINT Study. N England J Med 2017; 377:733-44.
Bress AP, Bellows BK, King J, Hess R, Beddhu S, Zhang Z, et al, for the SPRINT Research Group and the
SPRINT Economics and Health Related Quality of Life Subcommittee. Cost-Effectiveness of
Intensive versus Standard Blood Pressure Control. N England J Med 2017; 377:745-55.
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Appendix G
Examples of Tailored Text Messages

Vanessa Silverio NURSE PRACTITIONER
10/10/21
Time to prep for the week, try meal planning and bring your lunch to work every day this week!
Make it colorful - fruits and vegetables, lean meats.
VS
Vanessa Silverio NURSE PRACTITIONER
10/11/21
It’s Monday! Goal is to increase HDL’s (good fats), lower LDL’s (bad fats). Remember to take your
meds.
VS
Vanessa Silverio NURSE PRACTITIONER
10/12/21
Reminder to take your oral anti-diabetic medications.
VS
Vanessa Silverio NURSE PRACTITIONER
10/13/21
Portion control is key! An open palm, not including fingers and thumb, is about 3 oz. of cooked
boneless meat. This should be the size of your protein portion.
VS
Vanessa Silverio NURSE PRACTITIONER
10/14/21
A fist is about the size of 1 cup or 30 grams of food. This is a good portion of cereal, bread, or
starchy vegetables such as potatoes or corn. It is ok to eat carbs, but in moderation and in
portions.
VS
Vanessa Silverio NURSE PRACTITIONER
10/15/21
Finally the weekend is here! Time to make a list of healthy grocery items including lean meats
(boneless chicken breasts, Turkey slices, ground turkey), any type of fish, vegetables (celery sticks,
carrots, or red/yellow/orange peppers to munch on for snack during the week), fruits (berries
have less sugar than bananas), apples are in season now (slice them up and eat as a snack
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throughout the day next week). These are just ideas to get you thinking healthy the next time you
go to the grocery store.
VS
Vanessa Silverio NURSE PRACTITIONER
10/16/21
It’s the weekend and it is dry out; go out and exercise! The American Diabetes Association (ADA)
recommends 120 minutes per week of moderate-intensity exercise such as brisk walking.
VS
Vanessa Silverio NURSE PRACTITIONER
10/17/21
Time to prep for the week, bring your lunch & healthy snacks to work every day this week! Make
it colorful - fruits and vegetables and one high protein-rich food item. Remember to take your
diabetic medications.
VS
Vanessa Silverio NURSE PRACTITIONER
10/18/21
A new week! Let’s try to exercise at least 30 minutes three times a week this week; it can be 10
minutes in the morning before heading to work or during a break, another 10 minutes walking
around after lunch, and 10 minutes when you get home before eating dinner.
VS
Vanessa Silverio NURSE PRACTITIONER
10/19/21
Reminder to take your oral anti-diabetic medications. If you didn't get a chance to exercise
yesterday, do it today. No excuses, think of the long term goal and preventing complications of
Type 2 DM.
VS
Vanessa Silverio NURSE PRACTITIONER
10/20/21
The secret of getting ahead, is getting started...start with small changes every day then eventually
the positive change will become a routine/habit.
VS
Vanessa Silverio NURSE PRACTITIONER
10/21/21
Make your plate colorful with a variety of fruits and vegetables, lean proteins (turkey, chicken, or
fish). Increase your plain water intake, avoid drinking sugary drinks.
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VS
Vanessa Silverio NURSE PRACTITIONER
10/22/21
Remember to bring extra medications if you are going out of town, don't forget to take your
medications!
VS
Vanessa Silverio NURSE PRACTITIONER
10/23/21
Prioritize 20-30 minutes of brisk walking today!
VS
Vanessa Silverio NURSE PRACTITIONER
10/24/21
It's not too late to get a 20 minute exercise in, get that heart rate up and sweat!
VS
Vanessa Silverio NURSE PRACTITIONER
10/26/21
It finally feels like Fall weather! There may be puddles of water on the street, but it should not
stop you from exercising today. Bundle up and go for a 20 minute brisk walk.
VS
Vanessa Silverio NURSE PRACTITIONER
10/27/21
IT'S OK TO EAT CARBS. Carbs are an important part of a healthy meal plan. Watch portion sizes
and getting carbs from fruits, vegetables, whole grains, low-fat milk, and yogurt is important.
Balance out the amount of carbs you are taking in by the amount of exercise you are doing.
VS
Vanessa Silverio NURSE PRACTITIONER
10/28/21
HEALTHY FAT LIST: Avocado, organic and grass fed butter/ghee, extra virgin unrefined coconut
oil and extra virgin olive oils, fish like salmon, sardines, and anything wild-caught, nuts like
walnuts, cashews, and macademia, grass fed beef from trusted farmers, seeds like chia, pumpkin,
flax, and sunflower, eggs with yolk.
VS
Vanessa Silverio NURSE PRACTITIONER
10/29/21
Avoid Trans fat and some saturated fats also known as processed foods which raises LDL
cholesterol and lowers good HDL cholesterol. Think LDL is LETHAL, HDL is HEALTHY. Good
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fats are long lasting fuel source for metabolism, improves cognitive function, balances hormone
production, healthier organs and tissues (eye health).
VS
Vanessa Silverio NURSE PRACTITIONER
10/30/21
Halloween weekend! It is tempting to eat a piece of chocolate when it is everywhere in sight. It is
OK to have a small treat from time to time. If you have been following my daily suggestions, and
have exercised at least 30 minutes today, then go ahead and treat yourself.
Vanessa Silverio NURSE PRACTITIONER
11/8/21
Daylight savings time can be a benefit for you. Instead of sleeping in for that extra hour, why not
start your day earlier and prepare a healthy breakfast or do a quick 20 minute cardio to get your
day started!
VS
Vanessa Silverio NURSE PRACTITIONER
11/9/21
Reminder to take your oral anti-diabetic medications.
VS
Vanessa Silverio NURSE PRACTITIONER
11/10/21
Now that you have been eating less or being more physically active, your glucose levels are
lowering which is the goal. However, it is important to learn your own signs and symptoms of
when your blood glucose is too low, or you have a glucose reading of less than 70 mg/dl.
Symptoms of hypoglycemia include feeling shaky, being nervous or anxious, sweating, chills,
clamminess, mood swings, feeling "hangry," fast heartbeat, numbness/tingling to lips, tongue,
cheeks, feeling sleepy, blurry vision, etc. Low blood glucose can happen if you've skipped a meal,
even if you have no time to eat a full breakfast, grab a healthy snack to eat on your way to work.
VS
Vanessa Silverio NURSE PRACTITIONER
11/11/21
Still on the subject of hypoglycemia...if you think your glucose is low, check your blood glucose.
If your reading is less than 70 mg/dl, have 15 grams of carbohydrates to raise your blood glucose.
Examples are glucose tablets (read instructions), 1/2 cup of juice or regular soda, 1 tablespoon of
sugar, honey, or corn syrup, 1 cup of nonfat or 1% milk, hard candies, jellybeans. After 15
minutes, recheck your blood glucose and repeat if readings are still less than 70 mg/dl. Make a
note of your episode and let your provider know.
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VS
Vanessa Silverio NURSE PRACTITIONER
11/12/21
Prioritize 20-30 minutes of brisk walking today!
VS
Vanessa Silverio NURSE PRACTITIONER
11/12/21
It’s wet, windy, and cold outside…you may have had a long day and this weather is making you
even more tired…I get it. Try doing at least 5 minutes of some type of cardio when you get home,
if you complete 5 minutes, try going longer for at least 10 minutes. Goal is 20 minutes of any type
of cardio. You Can Do It!!
Vanessa Silverio NURSE PRACTITIONER
11/18/21
Reminder to take your oral anti-diabetic medications.
VS
Vanessa Silverio NURSE PRACTITIONER
11/19/21
If you already have an exercise routine then you are ahead of the game, kudos to you! Tips to
increase your activity would be taking the stairs instead of the elevator, parking your car at the far
end of the parking lot, taking a 30 minute walk, most days of the week, work in the yard (those
leaves aren't going to disappear on its own), do some housework, get up and move every 90
minutes if you sit for long periods of time.
VS
Vanessa Silverio NURSE PRACTITIONER
11/21/21
Time to redeem yourself if you have not worked out yet this weekend…start your Sunday right
by exercising at least 30 minutes. Meal prep for the week and don’t forget to take your
medications.
VS
Vanessa Silverio NURSE PRACTITIONER
11/22/21
"Weight lifting is a smart way for people of any fitness level to include anaerobic exercise in their
routine. Resistance training improves blood glucose control and helps the body use insulin more
efficiently. It also decreases fat mass, increases muscle mass and improves strength. People with
diabetes should aim for two or three resistance-training sessions per week" (ADA, 2021).
VS

81

Vanessa Silverio NURSE PRACTITIONER
11/23/21
Thanksgiving is in 2 days! You can still enjoy your typical Thanksgiving meal, just think
PORTION Control! When you are wanting to go up for seconds, drink a tall glass of water and
wait a few minutes after, or walk around the house or restaurant before considering seconds.
Bonus points for you if you exercise at least 30 minutes that day.
VS
Vanessa Silverio NURSE PRACTITIONER
11/24/21
If you are planning on cooking for Thanksgiving, why not try alternative healthier dishes such as
cauliflower mash instead of mashed potatoes, quinoa or brown rice instead of white rice, no bread
rolls at the dinner table, and lots of vegetable side dishes! A slice of pumpkin pie is about 320
calories...if you workout for at least 30 minutes that day, you will burn about 300 calories, as if
you've never eaten that slice of pie!
VS
Vanessa Silverio NURSE PRACTITIONER
11/25/21
Happy Thanksgiving! I am grateful for you being a part of my evidence-based practice project and
hoping you are benefiting from these daily texts. Enjoy the day with family and friends, but don't
forget to take your medications!

